[go: up one dir, main page]

CN102617572A - Tetracene-5,6:11,12-tetrabasic carboxylic acid diimide compound and preparation method thereof - Google Patents

Tetracene-5,6:11,12-tetrabasic carboxylic acid diimide compound and preparation method thereof Download PDF

Info

Publication number
CN102617572A
CN102617572A CN2011100334121A CN201110033412A CN102617572A CN 102617572 A CN102617572 A CN 102617572A CN 2011100334121 A CN2011100334121 A CN 2011100334121A CN 201110033412 A CN201110033412 A CN 201110033412A CN 102617572 A CN102617572 A CN 102617572A
Authority
CN
China
Prior art keywords
group
compound
substituted
unsubstituted
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011100334121A
Other languages
Chinese (zh)
Inventor
王朝晖
岳晚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Chemistry CAS
Original Assignee
Institute of Chemistry CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Chemistry CAS filed Critical Institute of Chemistry CAS
Priority to CN2011100334121A priority Critical patent/CN102617572A/en
Priority to PCT/CN2012/000096 priority patent/WO2012103776A1/en
Priority to TW101102697A priority patent/TW201309697A/en
Publication of CN102617572A publication Critical patent/CN102617572A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B57/00Other synthetic dyes of known constitution
    • C09B57/08Naphthalimide dyes; Phthalimide dyes
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/621Aromatic anhydride or imide compounds, e.g. perylene tetra-carboxylic dianhydride or perylene tetracarboxylic di-imide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P70/00Climate change mitigation technologies in the production process for final industrial or consumer products
    • Y02P70/50Manufacturing or production processes characterised by the final manufactured product

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Indole Compounds (AREA)
  • Thin Film Transistor (AREA)
  • Electroluminescent Light Sources (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)

Abstract

本发明涉及下式I的并四苯-5,6:11,12-四羧酸二酰亚胺类化合物、以及该化合物的制备方法,其中:R1、R2、R3、R4、R5、R6、R7、R8、R9和R10,相同或不同,分别独立地代表氢、取代或未被取代的,C1-30烷基、C1-30烷氧基、C3-30环烷基、C5-30芳基、C1-30烷基芳基、C1-30烷基杂芳基、C1-30烷基杂环基、C1-30亚烷基氧基烷基、C1-30亚烷基氧基芳基、C1-30亚烷基氧基杂芳基、C1-30亚烷基氧基杂环基。

Figure DEST_PATH_IMAGE001
The present invention relates to the naphthacene-5,6:11,12-tetracarboxylic acid diimide compound of the following formula I, and the preparation method of the compound, wherein: R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 , the same or different, independently represent hydrogen, substituted or unsubstituted, C1-30 alkyl, C1-30 alkoxy, C3- 30 cycloalkyl, C5-30 aryl, C1-30 alkyl aryl, C1-30 alkyl heteroaryl, C1-30 alkyl heterocyclyl, C1-30 alkylene oxyalkyl, C1- 30 alkyleneoxyaryl, C1-30 alkyleneoxyheteroaryl, C1-30 alkyleneoxyheterocyclic.
Figure DEST_PATH_IMAGE001

Description

并四苯-5,6:11,12-四羧酸二酰亚胺类化合物及其制备方法Naphthacene-5,6:11,12-tetracarboxylic acid diimides and preparation method thereof

技术领域 technical field

本发明涉及并四苯-5,6:11,12-四羧酸二酰亚胺类化合物、以及该化合物的制备方法,还涉及并四苯-5,6:11,12-四羧酸二酰亚胺类化合物在有机电致发光器件、有机热致色变元件、有机场效应晶体管、有机太阳能电池中作为吸光材料和电子传输材料的应用。 The present invention relates to naphthacene-5,6:11,12-tetracarboxylic acid diimide compound and the preparation method of the compound, and also relates to naphthacene-5,6:11,12-tetracarboxylic diimide Application of imide compounds as light-absorbing materials and electron-transporting materials in organic electroluminescent devices, organic thermochromic elements, organic field-effect transistors, and organic solar cells.

背景技术 Background technique

并苯类因为具有很大的共轭体系, 被发现具有良好的电荷传输特性,并显示出了良好的场效应性能并且在柔性电子器件(Chem. Rev. 2004, 104, 4891;Adv. Mater. 2002, 14, 99.)有着潜在的应用。蒽是目前被报道的体系最小的并苯类场效应性能材料,在温度较低时,其单晶迁移率约0.02 cm2/Vs(Appl. Phys. Lett. 2004, 84, 5383-5385.)。在十八烷基氯硅烷(ODTS)修饰的SiO2基底上,并四苯薄膜(Appl. Phys. Lett. 2002, 80, 2925-2927.)的迁移率达到0.1 cm2/Vs,其单晶(J. Appl. Phys. 2004, 96, 2080-2086.)迁移率可达1.3 cm2/Vs,开关比高达106Because of the large conjugated system, acenes have been found to have good charge transport properties, and have shown good field effect performance and are used in flexible electronic devices ( Chem. Rev. 2004, 104 , 4891; Ad v . Mater . 2002, 14 , 99.) have potential applications. Anthracene is the smallest acene-type field effect material reported so far, and its single crystal mobility is about 0.02 cm 2 /Vs when the temperature is low ( Appl. Phys. Lett. 2004, 84 , 5383-5385.) . On the octadecylchlorosilane (ODTS) modified SiO 2 substrate, the mobility of tetracene thin film ( Appl. Phys. Lett. 2002, 80 , 2925-2927.) reaches 0.1 cm 2 /Vs, and its single crystal ( J. Appl. Phys. 2004, 96 , 2080-2086.) The mobility can reach 1.3 cm 2 /Vs, and the on/off ratio can reach as high as 10 6 .

到目前为止对于并四苯的修饰仅有两类两类报道,一类是红荧烯,作为并四苯衍生物中的明星分子,尽管红荧烯的四个苯环取代基使整个分子并不是一个共平面体系,但四个侧位取代基却使相邻分子中心核间形成了较大的π-π重叠(Science. 2004, 303, 1644-1646.)。另一类是鲍哲南等人合成了一系列基于并四苯的卤代物。发现卤素的数量对于分子的堆积有密切关系,单个卤素取代的化合物呈现鱼骨状堆积,两个卤素取代的化合物呈现出滑移π堆积。基于的场效应晶体管显示了较大范围的迁移率,其中二溴取代物的迁移率高达1.6 cm2/Vs,可能归因于其较大的π重叠。(J. Am. Chem. Soc. 2004, 126, 15322-15323.)。 So far, there are only two types of reports on the modification of tetracene, one is rubrene, which is the star molecule in the derivatives of naphthacene, although the four benzene ring substituents of rubrene make the whole molecule and It is not a coplanar system, but the four side substituents make a large π-π overlap between the central cores of adjacent molecules ( Science. 2004, 303 , 1644-1646.). The other is a series of tetracene-based halides synthesized by Zhenan Bao et al. It is found that the number of halogens is closely related to the packing of molecules, the compound substituted by a single halogen presents a fishbone-like packing, and the compound substituted by two halogens presents a slip π stacking. Field-effect transistors based on β-based FETs show a wide range of mobilities, with dibromo-substituted mobilities as high as 1.6 cm 2 /Vs, possibly attributable to their larger π-overlap. ( J. Am. Chem. Soc. 2004, 126 , 15322-15323.).

本发明发明者发现,高迁移率的N-type材料可以通过强吸电子取代基功能化传统的P-type核而得到,比如说全氟取代的并五苯(J. Am. Chem. Soc. 2004, 126, 8138-8140),并五苯的全部氢被吸电子的氟原子所取代,一方面提高了并五苯的稳定性,另一方面使全氟并五苯表现出N-type有机半导体性质,同样,强吸电子的酰亚胺功能化苝以及萘,即苝酰亚胺(Angew. Chem. Int. Ed.  2010,  49, 740-743)和萘酰亚胺(Nature, 2000, 404, 478-481),都表现出优异的的N-type场效应性能而被广泛的研究。 The inventors of the present invention have found that high-mobility N-type materials can be obtained by functionalizing traditional P-type cores with strong electron-withdrawing substituents, such as perfluoro-substituted pentacene ( J. Am. Chem. Soc. 2004, 126 , 8138-8140), all the hydrogens of pentacene were replaced by electron-withdrawing fluorine atoms, on the one hand, the stability of pentacene was improved, and on the other hand, perfluoropentacene exhibited N-type organic Semiconductor properties, similarly, strong electron-withdrawing imide functionalized perylene and naphthalene, namely peryleneimide ( Angew. Chem. Int. Ed. 2010, 49 , 740-743 ) and naphthalimide ( Nature , 2000, 404 , 478-481), all exhibit excellent N-type field effect properties and have been extensively studied.

但是,本领域仍有需求获得强吸电子酰亚胺取代的并四苯-5,6:11,12-四羧酸二酰亚胺类化合物,特别地,本领域仍有需求获得一类并四苯-5,6:11,12-四羧酸二酰亚胺类化合物,其可以在的溶液在空气中放置数周其紫外吸收峰没有改变,即具有非常好的稳定性,应该可以作为空气中稳定的n-型电子传输材料。此外,本领域仍有需求所述类型并四苯-5,6:11,12-四羧酸二酰亚胺类化合物在可见光以及近红外(350-830nm)有较宽的吸收。进而,本领域仍有需求一种简单高效的合成上述化合物的制备方法,并需要具有较高产率的制备方法。 However, there is still a need in the art to obtain strongly electron-withdrawing imide-substituted naphthacene-5,6:11,12-tetracarboxylic acid diimides, in particular, there is still a need in the art to obtain a class of Tetraphenyl-5,6:11,12-tetracarboxylic acid diimide compounds, which can be placed in the air for several weeks, and their UV absorption peaks do not change, that is, they have very good stability, and should be used as Air-stable n-type electron transport materials. In addition, there is still a need in the art for the aforementioned naphthacene-5,6:11,12-tetracarboxylic diimides to have broad absorption in visible light and near-infrared (350-830 nm). Furthermore, there is still a need in the art for a simple and efficient preparation method for synthesizing the above compounds, and a preparation method with a higher yield.

发明内容 Contents of the invention

本发明的一个目的在于提供并四苯-5,6:11,12-四羧酸二酰亚胺类化合物。本发明的又一个目的在于提供制备上述目的化合物的方法。 One object of the present invention is to provide naphthacene-5,6:11,12-tetracarboxylic acid diimides. Another object of the present invention is to provide a method for preparing the above-mentioned object compound.

本发明涉及并四苯-5,6:11,12-四羧酸二酰亚胺化合物,其具有如下式I结构: The present invention relates to naphthacene-5,6:11,12-tetracarboxylic acid diimide compound, which has the following formula I structure:

Figure 98323DEST_PATH_IMAGE001
Figure 98323DEST_PATH_IMAGE001

其中: in:

R1、R2、R3、R4、R5、R6、R7、R8、R9和R10,相同或不同,分别独立地代表氢、取代或未被取代的,C1-30烷基、C1-30烷氧基、C3-30环烷基、C5-30芳基、C1-30烷基芳基、C1-30烷基杂芳基、C1-30烷基杂环基、C1-30亚烷基氧基烷基、C1-30亚烷基氧基芳基、C1-30亚烷基氧基杂芳基、C1-30亚烷基氧基杂环基, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 , the same or different, independently represent hydrogen, substituted or unsubstituted, C1-30 Alkyl, C1-30 alkoxy, C3-30 cycloalkyl, C5-30 aryl, C1-30 alkylaryl, C1-30 alkyl heteroaryl, C1-30 alkyl heterocyclic, C1 -30 alkyleneoxyalkyl, C1-30 alkyleneoxyaryl, C1-30 alkyleneoxyheteroaryl, C1-30 alkyleneoxyheterocyclic,

其中,任选地,R3和R4一起形成,取代或未被取代的,C3-30环烷基、C5-30芳基、C1-30烷基芳基、C1-30烷基杂芳基、C1-30烷基杂环基、C1-30亚烷基氧基芳基、C1-30亚烷基氧基杂芳基、C1-30亚烷基氧基杂环基, Wherein, optionally, R3 and R4 form together, substituted or unsubstituted, C3-30 cycloalkyl, C5-30 aryl, C1-30 alkylaryl, C1-30 alkylheteroaryl , C1-30 alkylene heterocyclic group, C1-30 alkylene oxyaryl group, C1-30 alkylene oxyheteroaryl group, C1-30 alkylene oxyheterocyclic group,

其中,任选地,R8和R9一起形成,取代或未被取代的,C3-30环烷基、C5-30芳基、C1-30烷基芳基、C1-30烷基杂芳基、C1-30烷基杂环基、C1-30亚烷基氧基芳基、C1-30亚烷基氧基杂芳基、C1-30亚烷基氧基杂环基, Wherein, optionally, R 8 and R 9 form together, substituted or unsubstituted, C3-30 cycloalkyl, C5-30 aryl, C1-30 alkylaryl, C1-30 alkylheteroaryl , C1-30 alkylene heterocyclic group, C1-30 alkylene oxyaryl group, C1-30 alkylene oxyheteroaryl group, C1-30 alkylene oxyheterocyclic group,

条件是:R2、R3、R4、R5、R7、R8、R9和R10不同时为氢。 Provided that R 2 , R 3 , R 4 , R 5 , R 7 , R 8 , R 9 and R 10 are not simultaneously hydrogen.

在本发明一个所述化合物实施方案中,R3和R4可以一起形成,或R8和R9可以一起形成,下述基团:取代或未被取代的,C3-30环烷基、C5-30芳基、C1-30烷基芳基、C1-30烷基杂芳基、C1-30烷基杂环基、C1-30亚烷基氧基芳基、C1-30亚烷基氧基杂芳基、C1-30亚烷基氧基杂环基。 In one embodiment of the compound of the present invention, R3 and R4 can form together, or R8 and R9 can form together, the following groups: substituted or unsubstituted, C3-30 cycloalkyl, C5 -30 aryl, C1-30 alkyl aryl, C1-30 alkyl heteroaryl, C1-30 alkyl heterocyclic, C1-30 alkylene oxyaryl, C1-30 alkylene oxy Heteroaryl, C1-30 alkyleneoxy heterocyclic group.

在本发明另一个所述化合物实施方案中,芳基选自,取代或未被取代的,苯基,萘基,蒽基,菲基,并四苯基,并五苯基,并六苯基,芘基,茚基,联苯基,芴基。 In another embodiment of said compounds of the present invention, aryl is selected from, substituted or unsubstituted, phenyl, naphthyl, anthracenyl, phenanthrenyl, naphthacene, pentacene, hexaphenyl , pyrenyl, indenyl, biphenyl, fluorenyl.

在本发明另一个所述化合物实施方案中,杂环基选自,取代或未被取代的,噻吩、呋喃、吡喃、吩

Figure 169047DEST_PATH_IMAGE002
噻、吡咯、咪唑、吡唑、吡啶、吡嗪、嘧啶、哒嗪、吲嗪、吲哚、异吲哚基、吲唑、嘌呤、喹嗪、喹啉、酞嗪、萘啶、喹喔啉、蝶啶、咔唑、咔啉、菲啶、菲咯啉、吖啶、吩嗪、噻唑、吩噻嗪、
Figure 284771DEST_PATH_IMAGE002
唑、吩
Figure 124551DEST_PATH_IMAGE002
嗪、
Figure 605211DEST_PATH_IMAGE002
唑基、
Figure 458504DEST_PATH_IMAGE002
二唑基、呋咱基、二噻吩并吡咯、三并噻吩、苯并
Figure 315601DEST_PATH_IMAGE002
唑基, 苯并咪唑基, 苯并噻吩, 苯并噻唑基、苯并噻吩、苯并呋喃、苯并吡喃、苯并吩噻、苯并吡咯、苯并咪唑、苯并吡唑、苯并吡啶、苯并吡嗪、苯并嘧啶、苯并哒嗪、苯并吲嗪、苯并吲哚、苯并吲唑、苯并嘌呤、苯并喹嗪、苯并喹啉、苯并酞嗪、苯并萘啶、苯并喹喔啉、苯并蝶啶、苯并咔唑、苯并咔啉、苯并菲啶、苯并菲咯啉、苯并吖啶、苯并吩嗪、苯并噻唑、苯并吩噻嗪、苯并
Figure 723766DEST_PATH_IMAGE002
唑、苯并吩
Figure 769082DEST_PATH_IMAGE002
嗪、或上述基团的环与上述权利要求2所定义芳基的环稠合衍生的基团,或上述基团的组合。这些取代基中的每一个可以另外被取代。 In another embodiment of said compound of the present invention, the heterocyclic group is selected from, substituted or unsubstituted, thiophene, furan, pyran, phen
Figure 169047DEST_PATH_IMAGE002
Thiothia, pyrrole, imidazole, pyrazole, pyridine, pyrazine, pyrimidine, pyridazine, indole, indole, isoindolyl, indazole, purine, quinozine, quinoline, phthalazine, naphthyridine, quinoxaline , pteridine, carbazole, carboline, phenanthridine, phenanthroline, acridine, phenazine, thiazole, phenothiazine,
Figure 284771DEST_PATH_IMAGE002
Azole, phen
Figure 124551DEST_PATH_IMAGE002
Zinc,
Figure 605211DEST_PATH_IMAGE002
Azolyl,
Figure 458504DEST_PATH_IMAGE002
Diazolyl, Furazanyl, Dithienopyrrole, Trithiophene, Benzo
Figure 315601DEST_PATH_IMAGE002
Azolyl, Benzimidazolyl, Benzothiophene, Benzothiazolyl, Benzothiophene, Benzofuran, Benzopyran, Benzophene Thiothia, benzopyrrole, benzimidazole, benzopyrazole, benzopyridine, benzopyrazine, benzopyrimidine, benzopyridazine, benzoinzine, benzoindole, benzoindazole, benzo Purine, benzoquinazine, benzoquinoline, benzophthalazine, benzonaphthyridine, benzoquinoxaline, benzopteridine, benzocarbazole, benzocarboline, benzophenanthridine, benzo phenanthroline, benzoacridine, benzophenazine, benzothiazole, benzophenothiazine, benzo
Figure 723766DEST_PATH_IMAGE002
Azole, Benzophene
Figure 769082DEST_PATH_IMAGE002
A group derived from oxazine, or the ring of the above-mentioned group fused with the ring of the aryl group defined in claim 2 above, or a combination of the above-mentioned groups. Each of these substituents may be additionally substituted.

在本发明另一个所述化合物实施方案中,烷基选自,取代或未被取代的甲基,乙基,丙基,异丙基,正丁基,仲丁基,异丁基,叔丁基,戊基,己基,庚基,辛基,壬基、癸基、十一碳烷基、十二碳烷基、十三碳烷基、十四碳烷基、十五碳烷基、十六碳烷基、十七碳烷基、十八碳烷基、十九碳烷基和二十碳烷基。 In another embodiment of said compound of the present invention, the alkyl group is selected from, substituted or unsubstituted methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl Base, Pentyl, Hexyl, Heptyl, Octyl, Nonyl, Decyl, Undecyl, Dodecyl, Tridecyl, Tetradecyl, Pentadecyl, Decyl Hexadecyl, Heptadecanyl, Octadecanyl, Nonadecanyl and Eicosyl.

在本发明另一个所述化合物实施方案中,烷氧基选自,取代或未被取代的甲氧基,乙氧基,丙氧基,异丙氧基,正丁氧基,仲丁氧基,异丁氧基,叔丁氧基,戊氧基,己氧基,庚氧基,辛氧基,壬氧基、癸氧基、十一碳烷氧基、十二碳烷氧基、十三碳烷氧基、十四碳烷氧基、十五碳烷氧基、十六碳烷氧基、十七碳烷氧基、十八碳烷氧基、十九碳烷氧基和二十碳烷氧基。 In another embodiment of said compounds of the present invention, alkoxy is selected from the group consisting of, substituted or unsubstituted methoxy, ethoxy, propoxy, isopropoxy, n-butoxy, sec-butoxy , isobutoxy, tert-butoxy, pentyloxy, hexyloxy, heptyloxy, octyloxy, nonyloxy, decyloxy, undecyloxy, dodecyloxy, tendecyloxy Tricarbonyloxy, tetradecyloxy, pentadecyloxy, hexadecanyloxy, heptadecanyloxy, octadecyloxy, ninedecyloxy and twenty carbon alkoxy.

在本发明另一个所述化合物实施方案中,亚烷基选自,取代或未被取代的亚甲基、亚乙基、亚丙基、亚异丙基、亚正丁基、亚仲丁基、亚异丁基、亚叔丁基、亚戊基、亚己基、亚庚基、亚辛基、亚壬基、亚癸基、亚十一碳烷基、亚十二碳烷基、亚十三碳烷基、亚十四碳烷基、亚十五碳烷基、亚十六碳烷基、亚十七碳烷基、亚十八碳烷基、亚十九碳烷基和亚二十碳烷基。 In another embodiment of said compound of the present invention, the alkylene group is selected from, substituted or unsubstituted methylene, ethylene, propylene, isopropylidene, n-butylene, sec-butylene , Isobutylene, tert-butylene, Pentylene, Hexylene, Heptylene, Octylene, Nonylene, Decylene, Undecylene, Dodecylene, Decylene Tricarbonyl, tetradecylene, pentadecylene, hexadecanylene, heptadecanylene, octadecylene, nonadecenylene and eicosylene carbon alkyl.

在本发明另一个所述化合物实施方案中,环烷基选自,取代或未被取代的环丁基、环戊基、环己基、环庚基、环辛基、环壬基、环癸基、十一碳环烷基、十二碳环烷基、十三碳环烷基、十四碳环烷基、十五碳环烷基、十六碳环烷基、十七碳环烷基、十八碳环烷基、十九碳环烷基和二十碳环烷基。 In another embodiment of said compound of the present invention, cycloalkyl is selected from, substituted or unsubstituted cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, cyclodecyl , Undecylcycloalkyl, Dodecylcycloalkyl, Tridecylcycloalkyl, Tetradecylcycloalkyl, Pentadecylcycloalkyl, Hexadecylcycloalkyl, Seventeen-carboncycloalkyl, Octadecylcycloalkyl, nineadecylcycloalkyl and eicoscycloalkyl.

在本发明另一个所述化合物实施方案中,杂芳基选自,取代或未被取代的,吡咯基、吡嗪基、吡啶基、吲哚基、异吲哚基、呋喃基、苯并呋喃基, 、异苯并呋喃基、喹啉基、1-异喹啉基、喹喔啉基、咔唑基、菲啶基、吖啶基、邻二氮杂菲基、吩嗪基、吩噻嗪基、吩噻嗪基、吩嗪基、唑基、呋呫基、噻吩基。 In another embodiment of said compounds of the present invention, heteroaryl is selected from, substituted or unsubstituted, pyrrolyl, pyrazinyl, pyridyl, indolyl, isoindolyl, furyl, benzofuran Base, , isobenzofuryl, quinolinyl, 1-isoquinolyl, quinoxalinyl, carbazolyl, phenanthridinyl, acridinyl, o-diazaphenanthrenyl, phenazinyl, phenothione Azinyl, phenothiazinyl, phen Azinyl, Azolyl, furanyl, thienyl.

在本发明另一个所述化合物实施方案中,R1、R2、R3、R4、R5、R6、R7、R8、R9和R10,相同或不同,分别独立地代表卤代C1-30烷基,优选地,全卤代C1-30烷基,其中优选地被氟、氯、溴、碘取代。 In another embodiment of the compounds of the present invention, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 , the same or different, independently represent Halogenated C1-30 alkyl, preferably, perhalogenated C1-30 alkyl, which is preferably substituted by fluorine, chlorine, bromine, iodine.

在本发明另一个所述化合物实施方案中,所述取代基选自: In another embodiment of said compound of the present invention, said substituent is selected from:

-烷基,其具有1-16碳原子, - alkyl, which has 1-16 carbon atoms,

-烷氧基,其具有1-16碳原子, - alkoxy, which has 1-16 carbon atoms,

-芳基,其具有5-16碳原子, - aryl, which has 5-16 carbon atoms,

-环烷基,其具有3-16碳原子, - cycloalkyl, which has 3-16 carbon atoms,

-杂环基团,其具有5-16碳原子,基团其中包含的杂原子T基团选自B, Si, Sn, N, O, S 和 Se; -Heterocyclic group, which has 5-16 carbon atoms, the heteroatom T group contained in the group is selected from B, Si, Sn, N, O, S and Se;

-杂芳基,其具有1-16碳原子, -heteroaryl, which has 1-16 carbon atoms,

-芳烷基,其具有5-16碳原子,其中烷基部分具有1-16碳原子。 - Aralkyl groups having 5-16 carbon atoms, wherein the alkyl moiety has 1-16 carbon atoms.

在本发明另一个所述化合物实施方案中,所述取代基选自: In another embodiment of said compound of the present invention, said substituent is selected from:

-烷基,如甲基,乙基,异丙基,叔丁基,正辛基,正癸基,正十二烷基, 正十四烷基, 正十六烷基或正十八烷基; - Alkyl groups such as methyl, ethyl, isopropyl, tert-butyl, n-octyl, n-decyl, n-dodecyl, n-tetradecyl, n-hexadecyl or n-octadecyl ;

-环烷基,如环丙基,环戊基,或环己基; - cycloalkyl, such as cyclopropyl, cyclopentyl, or cyclohexyl;

-链烯基,如乙烯基,烯丙基,2-丁烯基,或3-戊烯基;  - alkenyl, such as vinyl, allyl, 2-butenyl, or 3-pentenyl;

-炔基,如炔丙基或3-戊炔基, -alkynyl, such as propargyl or 3-pentynyl,

-芳基,如苯基,对-甲基苯基,萘基或蒽基; - aryl, such as phenyl, p-methylphenyl, naphthyl or anthracenyl;

-氨基,如氨基,甲基氨基,二甲基氨基,二乙基氨基,二苄基氨基,二苯基氨基,或二甲苯基氨基; -amino group, such as amino, methylamino, dimethylamino, diethylamino, dibenzylamino, diphenylamino, or xylylamino;

-烷氧基,如甲氧基,乙氧基,丁氧基或2-乙基己氧基; - alkoxy, such as methoxy, ethoxy, butoxy or 2-ethylhexyloxy;

-芳氧基,如苯基氧基,1-萘氧基,或2-萘氧基; -Aryloxy, such as phenyloxy, 1-naphthyloxy, or 2-naphthyloxy;

-杂芳氧基,如吡啶基氧基,吡唑基氧基,嘧啶基氧基或喹啉基氧基; -heteroaryloxy, such as pyridyloxy, pyrazolyloxy, pyrimidinyloxy or quinolinyloxy;

-酰基,如乙酰基,苯甲酰基,甲酰基或新戊酰基; - an acyl group such as acetyl, benzoyl, formyl or pivaloyl;

-烷氧基羰基,如甲氧基羰基或乙氧基羰基; - alkoxycarbonyl, such as methoxycarbonyl or ethoxycarbonyl;

-芳氧基羰基,如苯基氧基羰基; - aryloxycarbonyl, such as phenyloxycarbonyl;

-酰氧基,如乙酰氧基或苯甲酰氧基;  - acyloxy, such as acetoxy or benzoyloxy;

-酰胺基,如乙酰氨基或苯甲酰基氨基; - an amido group, such as acetamido or benzoylamino;

-烷氧基羰基氨基,如甲氧基羰基氨基; - alkoxycarbonylamino, such as methoxycarbonylamino;

-芳氧基氧基氨基,如苯基氧基羰基氨基; - aryloxyoxyamino, such as phenyloxycarbonylamino;

-磺酰基氨基,如甲烷磺酰基胺基或苯磺酰基氨基; - sulfonylamino, such as methanesulfonylamino or benzenesulfonylamino;

-氨磺酰基,如氨基磺酰基,甲基氨基磺酰基,二甲基氨基磺酰基,或苯基氨基磺酰基; - sulfamoyl, such as aminosulfonyl, methylaminosulfonyl, dimethylsulfamoyl, or phenylaminosulfonyl;

-氨基甲酰基,如氨基甲酰基,甲基氨基甲酰基,二乙基氨基甲酰基,或苯基氨基甲酰基; - carbamoyl, such as carbamoyl, methylcarbamoyl, diethylcarbamoyl, or phenylcarbamoyl;

-烷硫基,如甲硫基或乙硫基; - Alkylthio, such as methylthio or ethylthio;

-芳硫基,如苯硫基; -Arylthio, such as phenylthio;

-杂芳基硫基,如吡啶基硫基,2-苯并咪唑基硫基,2-苯并

Figure 863443DEST_PATH_IMAGE002
唑基硫基,或2-苯并噻唑基硫基;  -Heteroarylthio, such as pyridylthio, 2-benzimidazolylthio, 2-benzo
Figure 863443DEST_PATH_IMAGE002
Azolylthio, or 2-benzothiazolylthio;

-磺酰基,如甲磺酰基或甲苯磺酰基; -sulfonyl, such as methylsulfonyl or toluenesulfonyl;

-亚磺酰基,如甲基亚磺酰基或苯亚磺酰基; - sulfinyl, such as methylsulfinyl or phenylsulfinyl;

-脲基,如脲基,甲基脲基或苯基脲基; - ureido, such as ureido, methylureido or phenylureido;

-磷酸酰胺基,如二乙基磷酸酰胺或苯基磷酰胺; - Phosphoric amido groups, such as diethylphosphoramide or phenylphosphoramide;

-羟基; - Hydroxy;

-巯基;  - mercapto;

-卤素原子(如氟原子,氯原子,溴原子,或碘原子); - a halogen atom (such as a fluorine atom, a chlorine atom, a bromine atom, or an iodine atom);

-氰基; - cyano;

-磺基; - sulfo group;

-羧基; -carboxyl;

-硝基; - nitro;

-异羟肟酸基团; - hydroxamic acid group;

-亚磺基; - sulfinyl group;

-肼基; - hydrazino;

-亚氨基; - imino group;

-杂环基团,如咪唑基,吡啶基,喹啉基,呋喃基,噻吩基,哌啶基,吗啉代,苯并

Figure 130477DEST_PATH_IMAGE002
唑基,苯并咪唑基,和苯并噻唑基; - Heterocyclic groups such as imidazolyl, pyridyl, quinolinyl, furyl, thienyl, piperidyl, morpholino, benzo
Figure 130477DEST_PATH_IMAGE002
Azolyl, benzimidazolyl, and benzothiazolyl;

-甲硅烷基,如三甲基甲硅烷基或三苯基甲硅烷基。 - a silyl group, such as trimethylsilyl or triphenylsilyl.

在本发明另一个所述化合物实施方案中,所述化合物是: In another said compound embodiment of the invention, said compound is:

Figure 391694DEST_PATH_IMAGE003
Figure 794993DEST_PATH_IMAGE004
Figure 53936DEST_PATH_IMAGE005
Figure 391694DEST_PATH_IMAGE003
,
Figure 794993DEST_PATH_IMAGE004
,
Figure 53936DEST_PATH_IMAGE005

Figure 109059DEST_PATH_IMAGE007
or
Figure 109059DEST_PATH_IMAGE007
,

其中Et代表乙基,Bu代表丁基。 Wherein Et represents ethyl, and Bu represents butyl.

本发明还涉及制备上述化合物的方法,其包括下述步骤: The present invention also relates to the method for preparing above-mentioned compound, it comprises the following steps:

1). 使卤代茂金属试剂Cp2LX2与炔化合物B反应,得到式II和/或式III化合物: 1). Reaction of the halogenated metallocene reagent Cp 2 LX 2 with the alkyne compound B to obtain the compound of formula II and/or formula III:

Figure 632444DEST_PATH_IMAGE008
Figure 632444DEST_PATH_IMAGE008

和/或 and / or

Figure 124606DEST_PATH_IMAGE009
Figure 124606DEST_PATH_IMAGE009

其中, in,

R1、R2、R3、R4、R5、R6、R7、R8、R9和R10,相同或不同, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are the same or different,

定义如上所定义, Defined as defined above,

Cp代表环戊二烯基或称为茂基, Cp represents cyclopentadienyl or known as cyclopentadienyl,

L代表元素周期表中IVA或IVB族金属,如锆或钛, L represents the IVA or IVB group metals in the periodic table of elements, such as zirconium or titanium,

X代表卤素,如氟、氯、溴、碘, X represents halogen, such as fluorine, chlorine, bromine, iodine,

B代表炔化合物,如R≡R’,R-C≡C-(CH2)n-C≡C-R’’,或R-C≡C-(CH2)n-C≡C-(CH2)n-C≡C-R’’’,其中,R,R’,R’’和R’’’,相同或不同,代表如上述R1、R2、R3、R4、R5、R6、R7、R8、R9或R10所定义的基团或另外合适的保护基团,如三烃基硅基例如三甲基硅基、三异丙基硅或三苯基甲硅烷基,或芳基如苯基;n=3,4,5,6,7,8,9或10; B represents an alkyne compound, such as R≡R', RC≡C-(CH 2 ) n -C≡C-R'', or RC≡C-(CH 2 ) n -C≡C-(CH 2 ) n - C≡C-R''', wherein R, R', R'' and R''', the same or different, represent R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , A group defined by R 7 , R 8 , R 9 or R 10 or another suitable protecting group, such as a trihydrocarbylsilyl group such as trimethylsilyl, triisopropylsilyl or triphenylsilyl, or Aryl such as phenyl; n=3,4,5,6,7,8,9 or 10;

2). 使式IV四卤代四羧酸萘二酰亚胺化合物与前述步骤得到的式II和或式III化合物反应,得到式I化合物: 2). The compound of formula IV tetrahalogenated tetracarboxylic naphthalene diimide reacts with the compound of formula II and or formula III obtained in the previous step to obtain the compound of formula I:

Figure 100652DEST_PATH_IMAGE010
Figure 100652DEST_PATH_IMAGE010

Figure 641355DEST_PATH_IMAGE012
Figure 641355DEST_PATH_IMAGE012

其中, in,

R1、R2、R3、R4、R5、R6、R7、R8、R9和R10,相同或不同, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are the same or different,

定义如上所定义, Defined as defined above,

X,相同或不同,代表卤素,如氟、氯、溴、碘。 X, same or different, represents halogen, such as fluorine, chlorine, bromine, iodine.

在本发明另一个所述化合物制备方法的实施方案中,鉴于上述制备方法步骤1)中的式II和/或式III化合物的稳定性,优选地,R2、R5、R7和R10不同时代表氢。 In another embodiment of the preparation method of the compound of the present invention, in view of the stability of the compound of formula II and/or formula III in step 1) of the above preparation method, preferably, R 2 , R 5 , R 7 and R 10 does not represent hydrogen at the same time.

在本发明另一个所述化合物制备方法的实施方案中,本发明四卤代的四羧酸萘二酰亚胺类化合物是含有取代基或未含有取代基的2,3:6,7-四氯萘-5,6:11,12-四羧酸二酰亚胺化合物、2,3:6,7-四溴萘-5,6:11,12-四羧酸二酰亚胺化合物。所述的取代基是氢、C1~C30全氟代烷基、C1~C30烷基、C1~C30烷氧基或取代或未取代的芳基。 In another embodiment of the preparation method of the compound of the present invention, the tetrahalogenated tetracarboxylic naphthalene diimide compound of the present invention is 2,3:6,7-tetrahalogen with or without substituents Chloronaphthalene-5,6:11,12-tetracarboxylic diimide compound, 2,3:6,7-tetrabromonaphthalene-5,6:11,12-tetracarboxylic diimide compound. The substituent is hydrogen, C 1 -C 30 perfluoroalkyl, C 1 -C 30 alkyl, C 1 -C 30 alkoxy or substituted or unsubstituted aryl.

在本发明一个所述化合物制备方法的实施方案中,步骤1)中,将式VI化合物中加入溶剂,式VI化合物与溶剂的比例为0.01~1.0mmol/ml。 In one embodiment of the preparation method of the compound of the present invention, in step 1), a solvent is added to the compound of formula VI, and the ratio of the compound of formula VI to the solvent is 0.01-1.0 mmol/ml.

在本发明另一个所述化合物制备方法的实施方案中,四卤代四羧酸萘二酰亚胺化合物与式VI化合物的摩尔比例为1:1~10。 In another embodiment of the preparation method of the compound of the present invention, the molar ratio of the tetrahalogenated tetracarboxylic acid naphthalene diimide compound to the compound of formula VI is 1:1-10.

在本发明另一个所述化合物制备方法的实施方案中,向步骤1)产物中加入催化剂,催化剂与四卤代四羧酸萘二酰亚胺化合物摩尔比为10:1~1。 In another embodiment of the compound preparation method of the present invention, a catalyst is added to the product of step 1), and the molar ratio of the catalyst to the tetrahalogenated tetracarboxylic naphthalene diimide compound is 10:1-1.

在本发明另一个所述化合物制备方法的实施方案中,反应温度控制在0℃~70℃。 In another embodiment of the preparation method of the compound of the present invention, the reaction temperature is controlled at 0°C to 70°C.

在本发明另一个所述化合物制备方法的实施方案中,所述的催化剂为氯化亚铜。 In another embodiment of the preparation method of the compound of the present invention, the catalyst is cuprous chloride.

具体地,本发明的并四苯-5,6:11,12-四羧酸二酰亚胺类化合物的制备方法包括以下步骤: Specifically, the preparation method of the naphthacene-5,6:11,12-tetracarboxylic diimide compound of the present invention comprises the following steps:

(1).在惰性气体保护下,向锆试剂中加入四氢呋喃,锆试剂与溶剂的比例为0.01~1.0mmol/ml; (1). Under the protection of an inert gas, add tetrahydrofuran to the zirconium reagent, and the ratio of the zirconium reagent to the solvent is 0.01-1.0 mmol/ml;

(2).向步骤(1)制备的混合物中加入2,3:6,7-四卤代的四羧酸萘二酰亚胺类化合物。2,3:6,7-四卤代的四羧酸萘二酰亚胺类化合物与锆试剂的摩尔比例为1:2~10. (2). Add 2,3:6,7-tetrahalogenated tetracarboxylic naphthalimides to the mixture prepared in step (1). The molar ratio of 2,3:6,7-tetrahalogenated tetracarboxylic naphthalimide to zirconium reagent is 1:2~10.

(3).向步骤(2)制备的混合物中加入催化剂,催化剂与2,3:6,7-四卤代的四羧酸萘二酰亚胺类化合物摩尔比为10:1~1,反应温度控制在0℃~70℃,优选55℃。 (3). Add a catalyst to the mixture prepared in step (2), the molar ratio of catalyst to 2,3:6,7-tetrahalogenated tetracarboxylic naphthalimide compound is 10:1~1, react The temperature is controlled at 0°C to 70°C, preferably 55°C.

(4).反应结束,产物经二氯甲烷,乙酸乙酯或者甲苯等有机溶剂萃取,干燥剂干燥,蒸干溶剂,分离提纯得到并四苯-5,6:11,12-四羧酸二酰亚胺类化合物。 (4). After the reaction is completed, the product is extracted with organic solvents such as dichloromethane, ethyl acetate or toluene, dried with a desiccant, evaporated to dryness, separated and purified to obtain naphthacene-5,6:11,12-tetracarboxylic acid di imide compounds.

在本发明另一个所述化合物制备方法的实施方案中,所述的惰性气体包括氮气或氩气。 In another embodiment of the preparation method of the compound of the present invention, the inert gas includes nitrogen or argon.

在本发明另一个所述化合物制备方法的实施方案中,所述的萃取所用的有机溶剂是二氯甲烷、乙酸乙酯或甲苯。 In another embodiment of the preparation method of the compound of the present invention, the organic solvent used in the extraction is dichloromethane, ethyl acetate or toluene.

在本发明另一个所述化合物制备方法的实施方案中,步骤(1)所述的温度是0℃~70℃。 In another embodiment of the preparation method of the compound of the present invention, the temperature in step (1) is 0°C to 70°C.

本发明得到的目标产物经分离提纯后的产率在40%~55%。所得化合物经核磁共振图谱(1H-NMR)、质谱(MS)确证,如附图所示。 The yield of the target product obtained in the present invention after separation and purification is 40%-55%. The obtained compound was confirmed by nuclear magnetic resonance spectrum ( 1 H-NMR) and mass spectrum (MS), as shown in the accompanying drawing.

本发明所采用的原料均能够从市场上购买到或按照现有技术合成出;如锆试剂是按文献(J. Am. Chem. Soc.; 1989, 111, 3336-3346; J. Am. Chem. Soc.; 1987, 109, 2788-2796.; J. Am. Chem. Soc.; 1989, 111, 2870-2874; J. Org. Chem., 1995, 60, 4444 )报道方法合成的;卤代2,3:6,7-四卤代的四羧酸萘二酰亚胺类化合物是按文献(J. Org. Chem., 2007, 72, 8070-8075;Org. Lett.,2007, 9, 3917-3920)报道方法合成的。 The raw materials used in the present invention can be purchased from the market or synthesized according to the prior art; as the zirconium reagent is according to the literature ( J. Am. Chem. Soc.; 1989, 111, 3336-3346; J. Am. Chem . Soc.; 1987, 109, 2788-2796.; J. Am. Chem. Soc.; 1989, 111, 2870-2874; J. Org. Chem. , 1995, 60, 4444 ) reported method synthesis; 2,3:6,7-tetrahalogenated tetracarboxylic naphthalene diimides are based on literature ( J. Org. Chem. , 2007, 72, 8070-8075; Org. Lett., 2007, 9, 3917-3920) synthesized by the method reported.

本发明还涉及上述化合物在有机电致发光器件、有机热致色变元件、有机场效应晶体管、有机太阳能电池中作为吸光材料和电子传输材料的应用。 The invention also relates to the application of the above-mentioned compound as a light-absorbing material and an electron-transporting material in organic electroluminescent devices, organic thermochromic elements, organic field-effect transistors, and organic solar cells.

本发明还涉及有机电致发光器件、有机热致色变元件、有机场效应晶体管或有机太阳能电池,其包含上述化合物。 The present invention also relates to an organic electroluminescent device, an organic thermochromic element, an organic field effect transistor or an organic solar cell, which comprise the aforementioned compound.

用于本发明化合物中的芳基的例子包括但不限于苯基,萘基,蒽基,菲基,并四苯基,并五苯基,并六苯基,芘基,茚基,联苯基,邻-甲苯基,间-甲苯基,对-甲苯基,对-叔丁基苯基,对-(2-苯基丙基)苯基,3-甲基-2-萘基,4-甲基-1-萘基,4-甲基-1-蒽基,4’-甲基联苯基,4”-叔丁基-对-三联苯-4-基,9,9-二甲基芴-1-基,9,9-二甲基芴-2-基,9,9-二甲基芴-3-基,和9,9-二甲基芴-4-基。其它例子包括属于苯基,亚苯基,萘基和亚萘基的结合物的取代基(如苯基萘基,萘基苯基,萘基萘基,萘基萘基萘基,苯基苯基萘基,萘基萘基苯基,萘基苯基萘基,萘基苯基苯基,苯基萘基萘基,和苯基萘基苯基)。从具有6-8个碳原子的取代或未被取代芳基形成的基团是优选的。尤其,苯基,萘基和菲基是优选的。 Examples of aryl groups useful in the compounds of the present invention include, but are not limited to, phenyl, naphthyl, anthracenyl, phenanthrenyl, naphthacene, pentacene, hexaphenyl, pyrenyl, indenyl, biphenyl Base, o-tolyl, m-tolyl, p-tolyl, p-tert-butylphenyl, p-(2-phenylpropyl)phenyl, 3-methyl-2-naphthyl, 4- Methyl-1-naphthyl, 4-methyl-1-anthracenyl, 4'-methylbiphenyl, 4"-tert-butyl-p-terphenyl-4-yl, 9,9-dimethyl Fluoren-1-yl, 9,9-dimethylfluoren-2-yl, 9,9-dimethylfluoren-3-yl, and 9,9-dimethylfluoren-4-yl. Other examples include the Substituents for combinations of phenyl, phenylene, naphthyl and naphthylene (such as phenylnaphthyl, naphthylphenyl, naphthylnaphthyl, naphthylnaphthylnaphthyl, phenylphenylnaphthyl, Naphthylnaphthylphenyl, naphthylphenylnaphthyl, naphthylphenylphenyl, phenylnaphthylnaphthyl, and phenylnaphthylphenyl). From substituted or unsubstituted Groups formed by substituting an aryl group are preferred.In particular, phenyl, naphthyl and phenanthrenyl are preferred.

用于本发明化合物中的烷基的例子包括但不限于,甲基,乙基,丙基,异丙基,正丁基,仲丁基,异丁基,叔丁基,正戊基,正己基,正庚基,正辛基,壬基、癸基、十一碳烷基、十二碳烷基、十三碳烷基、十四碳烷基、十五碳烷基、十六碳烷基、十七碳烷基、十八碳烷基、十九碳烷基和二十碳烷基,羟甲基,1-羟乙基,2-羟乙基,2-羟基异丁基,1,2-二羟基乙基,1,3-二羟基异丙基,2,3-二羟基-叔丁基,1,2,3-三羟基丙基,氯甲基,1-氯乙基,2-氯乙基,2-氯异丁基,1,2-二氯乙基,1,3-二氯异丙基,2,3-二氯-叔丁基,1,2,3-三氯丙基,溴甲基,1-溴乙基,2-溴乙基,2-溴异丁基,1,2-二溴乙基,1,3-二溴异丙基,2,3-二溴-叔丁基,1,2,3-三溴丙基,一碘甲基,1-碘乙基,2-碘乙基,2-碘异丁基,1,2-二碘乙基,1,3-二碘异丙基,2,3-二碘-叔丁基,1,2,3-三碘丙基,一氨基甲基,1-氨基乙基,2-氨基乙基,2-氨基异丁基,1,2-二氨基乙基,1,3-二氨基异丙基,2,3-二氨基-叔丁基,1,2,3-三氨基丙基,氰基甲基,1-氰基乙基,2-氰基乙基,2-氰基异丁基,1,2-二氰基乙基,1,3-二氰基异丙基,2,3-二氰基-叔丁基,1,2,3-三氰基丙基,硝基甲基,1-硝基乙基,2-硝基乙基,2-硝基异丁基,1,2-二硝基乙基,1,3-二硝基异丙基,2,3-二硝基-叔丁基,和1,2,3-三硝基丙基。 Examples of alkyl groups useful in the compounds of the present invention include, but are not limited to, methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, n-hexyl radical, n-heptyl, n-octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecanyl Heptadecanyl, Octadecanyl, Nonadecanyl and Eicosyl, Hydroxymethyl, 1-Hydroxyethyl, 2-Hydroxyethyl, 2-Hydroxyisobutyl, 1 ,2-dihydroxyethyl, 1,3-dihydroxyisopropyl, 2,3-dihydroxy-tert-butyl, 1,2,3-trihydroxypropyl, chloromethyl, 1-chloroethyl, 2-chloroethyl, 2-chloroisobutyl, 1,2-dichloroethyl, 1,3-dichloroisopropyl, 2,3-dichloro-tert-butyl, 1,2,3-tri Chloropropyl, bromomethyl, 1-bromoethyl, 2-bromoethyl, 2-bromoisobutyl, 1,2-dibromoethyl, 1,3-dibromoisopropyl, 2,3- Dibromo-tert-butyl, 1,2,3-tribromopropyl, monoiodomethyl, 1-iodoethyl, 2-iodoethyl, 2-iodoisobutyl, 1,2-diiodoethyl , 1,3-diiodoisopropyl, 2,3-diiodo-tert-butyl, 1,2,3-triiodopropyl, monoaminomethyl, 1-aminoethyl, 2-aminoethyl, 2-aminoisobutyl, 1,2-diaminoethyl, 1,3-diaminoisopropyl, 2,3-diamino-tert-butyl, 1,2,3-triaminopropyl, cyano Methyl, 1-cyanoethyl, 2-cyanoethyl, 2-cyanoisobutyl, 1,2-dicyanoethyl, 1,3-dicyanoisopropyl, 2,3- Dicyano-tert-butyl, 1,2,3-tricyanopropyl, nitromethyl, 1-nitroethyl, 2-nitroethyl, 2-nitroisobutyl, 1,2 - dinitroethyl, 1,3-dinitroisopropyl, 2,3-dinitro-tert-butyl, and 1,2,3-trinitropropyl.

用于本发明化合物中的杂环基团的例子包括但不限于,噻吩基、呋喃基、吡喃基、吩

Figure 347142DEST_PATH_IMAGE002
噻基、吡咯基、咪唑基、吡唑基、吡啶基、吡嗪基、嘧啶基、哒嗪基、吲嗪基、吲哚基、吲唑基、嘌呤基、喹嗪基、喹啉基、酞嗪基、萘啶基、喹喔啉基、蝶啶基、咔唑基、咔啉基、菲啶基、菲咯啉基、吖啶基、吩嗪基、噻唑基、吩噻嗪基、
Figure 682309DEST_PATH_IMAGE002
唑基、吩嗪基、二噻吩并吡咯基、三并噻吩基、苯并
Figure 552362DEST_PATH_IMAGE002
唑基基, 苯并咪唑基, 苯并噻吩基, 苯并噻唑基、苯并噻吩基、苯并呋喃基、苯并吡喃基、苯并吩
Figure 50339DEST_PATH_IMAGE002
噻基、苯并吡咯基、苯并咪唑基、苯并吡唑基、苯并吡啶基、苯并吡嗪基、苯并嘧啶基、苯并哒嗪基、苯并吲嗪基、苯并吲哚基、苯并吲唑基、苯并嘌呤基、苯并喹嗪基、苯并喹啉基、苯并酞嗪基、苯并萘啶基、苯并喹喔啉基、苯并蝶啶基、苯并咔唑基、苯并咔啉基、苯并菲啶基、苯并菲咯啉基、苯并吖啶基、苯并吩嗪基、苯并噻唑基、苯并吩噻嗪基、苯并唑基、苯并吩
Figure 772625DEST_PATH_IMAGE002
嗪基、或上述基团的环与上述芳基的环、上述杂环基的环和/或上述杂芳基的环稠合衍生的基团,或上述基团的组合。这些取代基中的每一个可以另外被取代。 Examples of heterocyclic groups useful in compounds of the present invention include, but are not limited to, thienyl, furyl, pyranyl, phen
Figure 347142DEST_PATH_IMAGE002
Thiyl, pyrrolyl, imidazolyl, pyrazolyl, pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, indolyl, indolyl, indazolyl, purinyl, quinozinyl, quinolinyl, Phthalazinyl, naphthyridinyl, quinoxalinyl, pteridinyl, carbazolyl, carbolinyl, phenanthridinyl, phenanthrolinyl, acridinyl, phenazinyl, thiazolyl, phenothiazinyl,
Figure 682309DEST_PATH_IMAGE002
Azolyl, phen Azinyl, dithienopyrrolyl, trithienyl, benzo
Figure 552362DEST_PATH_IMAGE002
Azolyl, Benzimidazolyl, Benzothienyl, Benzothiazolyl, Benzothienyl, Benzofuryl, Benzopyranyl, Benzophene
Figure 50339DEST_PATH_IMAGE002
Thiyl, benzopyrrolyl, benzoimidazolyl, benzopyrazolyl, benzopyridyl, benzopyrazinyl, benzopyrimidinyl, benzopyridazinyl, benzoindolizinyl, benzoin Indolyl, benzoindazolyl, benzopurinyl, benzoquinazinyl, benzoquinolinyl, benzophthalazinyl, benzonaphthyridinyl, benzoquinoxalinyl, benzopteridinyl , benzocarbazolyl, benzocarbolinyl, benzophenanthridinyl, benzophenanthrolinyl, benzoacridinyl, benzophenazinyl, benzothiazolyl, benzophenothiazinyl, Benzo Azolyl, benzophene
Figure 772625DEST_PATH_IMAGE002
An azinyl group, or a group derived from the fusion of the ring of the above-mentioned group with the ring of the above-mentioned aryl group, the ring of the above-mentioned heterocyclic group and/or the ring of the above-mentioned heteroaryl group, or a combination of the above-mentioned groups. Each of these substituents may be additionally substituted.

进一步取代在每一个本发明化合物中各基团的取代基的例子包括:烷基(具有优选1-30个,更优选1-20个,如甲基,乙基,异丙基,叔丁基,正辛基,正癸基,正十二烷基, 正十四烷基, 正十六烷基或正十八烷基);环烷基(具有优选3-30个,更优选3-20个,或特别优选3-10个碳原子,如环丙基,环戊基,或环己基);链烯基(具有优选2-30个,更优选2-20个,或特别优选2-10个碳原子,如乙烯基,烯丙基,2-丁烯基,或3-戊烯基);炔基(具有优选2-30个,更优选2-20个,或特别优选2-10个碳原子,如炔丙基或3-戊炔基),芳基(具有优选6-30个,更优选6-20个,或特别优选6-12个碳原子,如苯基,对-甲基苯基,萘基或蒽基);氨基(具有优选0-30个,更优选0-20个,或特别优选0-10个碳原子,如氨基,甲基氨基,二甲基氨基,二乙基氨基,二苄基氨基,二苯基氨基,或二甲苯基氨基);烷氧基(具有优选1-30个,更优选1-20个,或特别优选1-10个碳原子,如甲氧基,乙氧基,丁氧基或2-乙基己氧基);芳氧基(具有优选6-30个,更优选6-20个,或特别优选6-12个碳原子,如苯基氧基,1-萘氧基,或2-萘氧基);杂芳氧基(具有优选1-30个,更优选1-20个,或特别优选1-12个碳原子,如吡啶基氧基,吡唑基氧基,嘧啶基氧基或喹啉基氧基);酰基(具有优选1-30个,更优选1-20个,或特别优选1-12个碳原子,如乙酰基,苯甲酰基,甲酰基或新戊酰基);烷氧基羰基(具有优选2-30个,更优选2-20个,或特别优选2-12个碳原子,如甲氧基羰基或乙氧基羰基);芳氧基羰基(具有优选7-30个,更优选7-20个,或特别优选7-12个碳原子,如苯基氧基羰基);酰氧基(具有优选2-30个,更优选2-20个,或特别优选2-10个碳原子,如乙酰氧基或苯甲酰氧基); 酰胺基(具有优选2-30个,更优选2-20个,或特别优选2-10个碳原子,如乙酰氨基或苯甲酰基氨基);烷氧基羰基氨基(具有优选2-30个,更优选2-20个,或特别优选2-12个碳原子,如甲氧基羰基氨基);芳氧基氧基氨基(具有优选7-30个,更优选7-20个,或特别优选7-12个碳原子,如苯基氧基羰基氨基);磺酰基氨基(具有优选1-30个,更优选1-20个,或特别优选1-12个碳原子,如甲烷磺酰基胺基或苯磺酰基氨基);氨磺酰基(具有优选0-30个,更优选0-20个,或特别优选0-12个碳原子,如氨基磺酰基,甲基氨基磺酰基,二甲基氨基磺酰基,或苯基氨基磺酰基); 氨基甲酰基(具有优选1-30个,更优选1-20个,或特别优选1-12个碳原子,如氨基甲酰基,甲基氨基甲酰基,二乙基氨基甲酰基,或苯基氨基甲酰基);烷硫基(具有优选1-30个,更优选1-20个,或特别优选1-12个碳原子,如甲硫基或乙硫基);芳硫基(具有优选6-30个,更优选6-20个,或特别优选6-12个碳原子,如苯硫基);杂芳基硫基(具有优选1-30个,更优选1-20个,或特别优选1-12个碳原子,如吡啶基硫基,2-苯并咪唑基硫基,2-苯并唑基硫基,或2-苯并噻唑基硫基); 磺酰基(具有优选1-30个,更优选1-20个,或特别优选1-12个碳原子,如甲磺酰基或甲苯磺酰基);亚磺酰基(具有优选1-30个,更优选1-20个,或特别优选1-12个碳原子,如甲基亚磺酰基或苯亚磺酰基);脲基(具有优选1-30个,更优选1-20个,或特别优选1-12个碳原子,如脲基,甲基脲基或苯基脲基);磷酸酰胺基(具有优选1-30个,更优选1-20个或特别优选1-12个碳原子,如二乙基磷酸酰胺或苯基磷酰胺);羟基;巯基; 卤素原子(如氟原子,氯原子,溴原子,或碘原子);氰基;磺基;羧基;硝基;异羟肟酸基团;亚磺基;肼基;亚氨基;杂环基团(具有优选1-30个或优选1-12个碳原子并含有作为杂原子的例如氮原子、氧原子或硫原子,以及特定的例子包括咪唑基,吡啶基,喹啉基,呋喃基,噻吩基,哌啶基,吗啉代,苯并

Figure 568466DEST_PATH_IMAGE002
唑基,苯并咪唑基,和苯并噻唑基);和甲硅烷基(具有优选3-40个,更优选3-30个,或特别优选3-24个碳原子,如三甲基甲硅烷基或三苯基甲硅烷基)。这些取代基中的每一个可以另外被取代。 Examples of substituents further substituting each group in each of the compounds of the present invention include: alkyl (having preferably 1-30, more preferably 1-20, such as methyl, ethyl, isopropyl, tert-butyl , n-octyl, n-decyl, n-dodecyl, n-tetradecyl, n-hexadecyl or n-octadecyl); cycloalkyl (with preferably 3-30, more preferably 3-20 , or particularly preferably 3-10 carbon atoms, such as cyclopropyl, cyclopentyl, or cyclohexyl); alkenyl (having preferably 2-30, more preferably 2-20, or particularly preferably 2-10 carbon atoms, such as vinyl, allyl, 2-butenyl, or 3-pentenyl); alkynyl (having preferably 2-30, more preferably 2-20, or particularly preferably 2-10 carbon atoms, such as propargyl or 3-pentynyl), aryl (with preferably 6-30, more preferably 6-20, or particularly preferably 6-12 carbon atoms, such as phenyl, p-methyl phenyl, naphthyl or anthracenyl); amino group (having preferably 0-30, more preferably 0-20, or particularly preferably 0-10 carbon atoms, such as amino, methylamino, dimethylamino, diethylamino ylamino, dibenzylamino, diphenylamino, or xylylamino); alkoxy (having preferably 1-30, more preferably 1-20, or particularly preferably 1-10 carbon atoms, such as methyl oxy, ethoxy, butoxy or 2-ethylhexyloxy); aryloxy (having preferably 6-30, more preferably 6-20, or particularly preferably 6-12 carbon atoms, such as benzene yloxy, 1-naphthyloxy, or 2-naphthyloxy); heteroaryloxy (having preferably 1-30, more preferably 1-20, or particularly preferably 1-12 carbon atoms, such as pyridyl oxy, pyrazolyloxy, pyrimidinyloxy or quinolinyloxy); acyl (having preferably 1-30, more preferably 1-20, or particularly preferably 1-12 carbon atoms, such as acetyl , benzoyl, formyl or pivaloyl); alkoxycarbonyl (having preferably 2-30, more preferably 2-20, or particularly preferably 2-12 carbon atoms, such as methoxycarbonyl or ethoxy ylcarbonyl); aryloxycarbonyl (having preferably 7-30, more preferably 7-20, or particularly preferably 7-12 carbon atoms, such as phenyloxycarbonyl); acyloxy (having preferably 2-30 , more preferably 2-20, or particularly preferably 2-10 carbon atoms, such as acetoxy or benzoyloxy); amido (with preferably 2-30, more preferably 2-20, or particularly preferably 2-10 carbon atoms, such as acetylamino or benzoylamino); alkoxycarbonylamino (with preferably 2-30, more preferably 2-20, or particularly preferably 2-12 carbon atoms, such as methyl oxycarbonylamino); aryloxyoxyamino (having preferably 7-30, more preferably 7-20, or particularly preferably 7-12 carbon atoms, such as phenyloxycarbonylamino); sulfonylamino ( Having preferably 1-30, more preferably 1-20, or particularly preferably 1-12 carbon atoms, such as methanesulfonylamino or benzenesulfonylamino); sulfamoyl (with preferred 0-30, more preferably 0-20, or particularly preferably 0-12 carbon atoms, such as aminosulfonyl, methylaminosulfonyl, dimethylaminosulfonyl, or phenylaminosulfonyl); Aminomethyl Acyl (having preferably 1-30, more preferably 1-20, or particularly preferably 1-12 carbon atoms, such as carbamoyl, methylcarbamoyl, diethylcarbamoyl, or phenylcarbamoyl ); alkylthio (having preferably 1-30, more preferably 1-20, or particularly preferably 1-12 carbon atoms, such as methylthio or ethylthio); arylthio (having preferably 6-30 , more preferably 6-20, or particularly preferably 6-12 carbon atoms, such as phenylthio); heteroarylthio (with preferably 1-30, more preferably 1-20, or particularly preferably 1-12 carbon atoms, such as pyridylthio, 2-benzimidazolylthio, 2-benzo Azolylthio, or 2-benzothiazolylthio); sulfonyl (having preferably 1-30, more preferably 1-20, or particularly preferably 1-12 carbon atoms, such as methylsulfonyl or toluenesulfonyl acyl); sulfinyl (with preferably 1-30, more preferably 1-20, or particularly preferably 1-12 carbon atoms, such as methylsulfinyl or phenylsulfinyl); ureido (with preferably 1 -30, more preferably 1-20, or particularly preferably 1-12 carbon atoms, such as ureido, methylureido or phenylureido); Phosphate amido group (with preferably 1-30, more preferably 1 -20 or particularly preferably 1-12 carbon atoms, such as diethylphosphoramide or phenylphosphoramide); hydroxyl; mercapto; halogen atom (such as fluorine atom, chlorine atom, bromine atom, or iodine atom); ; sulfo; carboxyl; nitro; hydroxamic acid group; sulfinyl; hydrazino; imino; heterocyclic group (having preferably 1-30 or preferably 1-12 carbon atoms and containing For example nitrogen atom, oxygen atom or sulfur atom, and specific examples include imidazolyl, pyridyl, quinolinyl, furyl, thienyl, piperidyl, morpholino, benzo
Figure 568466DEST_PATH_IMAGE002
Azolyl, benzimidazolyl, and benzothiazolyl); and a silyl group (having preferably 3-40, more preferably 3-30, or particularly preferably 3-24 carbon atoms, such as trimethylsilyl group or triphenylsilyl). Each of these substituents may be additionally substituted.

用于本发明的烷氧基的实例包括,但不限于,其中烷基部分与上述烷基定义相同,如乙基甲基氧基, 乙基氧基, 丙基氧基, 异丙基氧基, n-丁基氧基, s-丁基氧基, 异丁基氧基, 叔-丁基氧基, n-戊基氧基, n-己氧基, n-庚基氧基, 正-辛基氧基, 羟基乙基甲基氧基, 1-羟基乙基氧基, 2-羟基乙基氧基, 2-羟基异丁基氧基, 1,2-二羟基乙基氧基, 1,3-二羟基异丙基氧基, 2,3-二羟基-叔-丁基氧基, 1,2,3-三羟基丙基氧基, 氯乙基甲基氧基, 1-氯乙基氧基, 2-氯乙基氧基, 2-氯异丁基氧基, 1,2-二氯乙基氧基, 1,3-二氯异丙基氧基, 2,3-二氯-叔-丁基氧基, 1,2,3-三氯丙基氧基, 溴乙基甲基氧基, 1-溴乙基氧基, 2-溴乙基氧基, 2-溴异丁基氧基, 1,2-二溴乙基氧基, 1,3-二溴异丙基氧基, 2,3-二溴-叔-丁基氧基, 1,2,3-三溴丙基氧基, 碘乙基甲基氧基, 1-碘乙基氧基, 2-碘乙基氧基, 2-碘异丁基氧基, 1,2-二碘乙基氧基, 1,3-二碘异丙基氧基, 2,3-二碘-叔-丁基氧基, 1,2,3-三碘丙基氧基, 氨基乙基甲基氧基, 1-氨基乙基氧基, 2-氨基乙基氧基, 2-氨基异丁基氧基, 1,2-二氨基乙基氧基, 1,3-二氨基异丙基氧基, 2,3-二氨基-叔-丁基氧基, 1,2,3-三氨基丙基氧基, 氰基乙基甲基氧基, 1-氰基乙基氧基, 2-氰基乙基氧基, 2-氰基异丁基氧基, 1,2-二氰基乙基氧基, 1,3-二氰基异丙基氧基, 2,3-二氰基-叔-丁基氧基, 1,2,3-三氰基丙基氧基, 硝基乙基甲基氧基, 1-硝基乙基氧基, 2-硝基乙基氧基, 2-硝基异丁基氧基, 1,2-二硝基乙基氧基, 1,3-二硝基异丙基氧基, 2,3-二硝基-叔-丁基氧基, 1,2,3-三硝基丙基氧基。 Examples of the alkoxy group used in the present invention include, but are not limited to, wherein the alkyl moiety has the same definition as the above-mentioned alkyl group, such as ethylmethyloxy, ethyloxy, propyloxy, isopropyloxy , n-butyloxy, s-butyloxy, isobutyloxy, tert-butyloxy, n-pentyloxy, n-hexyloxy, n-heptyloxy, n- Octyloxy, Hydroxyethylmethyloxy, 1-Hydroxyethyloxy, 2-Hydroxyethyloxy, 2-Hydroxyisobutyloxy, 1,2-Dihydroxyethyloxy, 1 ,3-dihydroxyisopropyloxy, 2,3-dihydroxy-tert-butyloxy, 1,2,3-trihydroxypropyloxy, chloroethylmethyloxy, 1-chloroethyl Oxyloxy, 2-Chloroethyloxy, 2-Chloroisobutyloxy, 1,2-Dichloroethyloxy, 1,3-Dichloroisopropyloxy, 2,3-Dichloro -tert-butyloxy, 1,2,3-trichloropropyloxy, bromoethylmethyloxy, 1-bromoethyloxy, 2-bromoethyloxy, 2-bromoisobutyl 1,2-dibromoethyloxy, 1,3-dibromoisopropyloxy, 2,3-dibromo-tert-butyloxy, 1,2,3-tribromopropane yloxy, iodoethylmethyloxy, 1-iodoethyloxy, 2-iodoethyloxy, 2-iodoisobutyloxy, 1,2-diiodoethyloxy, 1, 3-Diiodoisopropyloxy, 2,3-Diiodo-tert-Butyloxy, 1,2,3-Triiodopropyloxy, Aminoethylmethyloxy, 1-Aminoethyl Oxygen, 2-aminoethyloxy, 2-aminoisobutyloxy, 1,2-diaminoethyloxy, 1,3-diaminoisopropyloxy, 2,3-diamino- tert-Butyloxy, 1,2,3-triaminopropyloxy, cyanoethylmethyloxy, 1-cyanoethyloxy, 2-cyanoethyloxy, 2-cyano Isobutyloxy, 1,2-dicyanoethyloxy, 1,3-dicyanoisopropyloxy, 2,3-dicyano-tert-butyloxy, 1,2 ,3-tricyanopropyloxy, nitroethylmethyloxy, 1-nitroethyloxy, 2-nitroethyloxy, 2-nitroisobutyloxy, 1, 2-Dinitroethyloxy, 1,3-Dinitroisopropyloxy, 2,3-Dinitro-tert-butyloxy, 1,2,3-Trinitropropyloxy base.

附图说明 Description of drawings

图1.本发明实施例1的1,2,3,4,7,8,9,10–八(乙基)-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺的质谱图。 Figure 1. 1,2,3,4,7,8,9,10-octa(ethyl)-N,N'-di(n-octyl)-tetracene-5,6 of Example 1 of the present invention : Mass spectrum of 11,12-tetracarboxylic diimide.

图2.本发明实施例1的1,2,3,4,7,8,9,10–八(乙基)-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺1H-NMR图。 Figure 2. 1,2,3,4,7,8,9,10-octa(ethyl)-N,N'-di(n-octyl)-tetracene-5,6 of Example 1 of the present invention : 1 H-NMR chart of 11,12-tetracarboxylic diimide.

图3.本发明实施例1的1,2,3,4,7,8,9,10–八(乙基)-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺的吸收图。 Figure 3. 1,2,3,4,7,8,9,10-octa(ethyl)-N,N'-di(n-octyl)-tetracene-5,6 of Example 1 of the present invention : Absorption diagram of 11,12-tetracarboxylic diimide.

图4.本发明实施例1的1,2,3,4,7,8,9,10–八(乙基)-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺的电化学图。 Figure 4. 1,2,3,4,7,8,9,10-octa(ethyl)-N,N'-di(n-octyl)-tetracene-5,6 of Example 1 of the present invention : Electrochemical diagram of 11,12-tetracarboxylic diimide.

图5.本发明实施例2的1,2,3,4,7,8,9,10–八(乙基)-N,N’-二(2,2,3,3,4,4,4–七氟正丁基)-并四苯-5,6:11,12-四羧酸二酰亚胺质谱图。 Figure 5. 1,2,3,4,7,8,9,10-octa(ethyl)-N,N'-di(2,2,3,3,4,4, Mass spectrum of 4-heptafluoro-n-butyl)-tetracene-5,6:11,12-tetracarboxylic diimide.

图6.本发明实施例2的1,2,3,4,7,8,9,10–八(乙基)-N,N’-二(2,2,3,3,4,4,4–七氟正丁基)-并四苯-5,6:11,12-四羧酸二酰亚胺的1H-NMR图。 Figure 6. 1,2,3,4,7,8,9,10-octa(ethyl)-N,N'-di(2,2,3,3,4,4, 1 H-NMR chart of 4-heptafluoro-n-butyl)-tetracene-5,6:11,12-tetracarboxylic acid diimide.

图7.本发明实施例2的1,2,3,4,7,8,9,10–八(乙基)-N,N’-二(2,2,3,3,4,4,4–七氟正丁基)-并四苯-5,6:11,12-四羧酸二酰亚胺吸收图。 Figure 7. 1,2,3,4,7,8,9,10-octa(ethyl)-N,N'-di(2,2,3,3,4,4, Absorption pattern of 4-heptafluoro-n-butyl)-tetracene-5,6:11,12-tetracarboxylic diimide.

图8.本发明实施例2的1,2,3,4,7,8,9,10–八(乙基)-N,N’-二(2,2,3,3,4,4,4–七氟正丁基)-并四苯-5,6:11,12-四羧酸二酰亚胺电化学图。 Figure 8. 1,2,3,4,7,8,9,10-octa(ethyl)-N,N'-di(2,2,3,3,4,4, Electrochemical diagram of 4-heptafluoro-n-butyl)-tetracene-5,6:11,12-tetracarboxylic acid diimide.

图9.本发明实施例3的1,2,3,4,7,8,9,10–八(正丁基)-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺的质谱图。 Figure 9. 1,2,3,4,7,8,9,10-octa(n-butyl)-N,N'-di(n-octyl)-tetracene-5 of Example 3 of the present invention, 6: The mass spectrum of 11,12-tetracarboxylic diimide.

图10. 本发明实施例3的1,2,3,4,7,8,9,10–八(正丁基)-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺1H-NMR图。 Figure 10. 1,2,3,4,7,8,9,10-octa(n-butyl)-N,N'-di(n-octyl)-tetracene-5 of Example 3 of the present invention, 6: 1 H-NMR chart of 11,12-tetracarboxylic diimide.

图11. 本发明实施例3的1,2,3,4,7,8,9,10–八(正丁基)-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺的吸收图。 Figure 11. 1,2,3,4,7,8,9,10-octa(n-butyl)-N,N'-di(n-octyl)-tetracene-5 of Example 3 of the present invention, 6: Absorption diagram of 11,12-tetracarboxylic diimide.

图12. 本发明实施例3的1,2,3,4,7,8,9,10–八(正丁基)-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺的电化学图。 Figure 12. 1,2,3,4,7,8,9,10-octa(n-butyl)-N,N'-di(n-octyl)-tetracene-5 of Example 3 of the present invention, 6: Electrochemical diagram of 11,12-tetracarboxylic diimide.

图13. 本发明实施例4的5,8,13,16–四(乙基)-1,2,3,4,9,10,11,12-八氢环己烷-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺的质谱图。 Figure 13. 5,8,13,16-tetra(ethyl)-1,2,3,4,9,10,11,12-octahydrocyclohexane-N,N'- of Example 4 of the present invention The mass spectrum of bis(n-octyl)-tetracene-5,6:11,12-tetracarboxylic acid diimide.

图14. 本发明实施例4的5,8,13,16–四(乙基)-1,2,3,4,9,10,11,12-八氢环己烷-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺的1H-NMR图。 Figure 14. 5,8,13,16-tetra(ethyl)-1,2,3,4,9,10,11,12-octahydrocyclohexane-N,N'- of Example 4 of the present invention 1 H-NMR chart of bis(n-octyl)-tetracene-5,6:11,12-tetracarboxylic diimide.

图15. 本发明实施例4的5,8,13,16–四(乙基)-1,2,3,4,9,10,11,12-八氢环己烷-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺的吸收图。 Figure 15. 5,8,13,16-tetra(ethyl)-1,2,3,4,9,10,11,12-octahydrocyclohexane-N,N'- of Example 4 of the present invention Absorption pattern of bis(n-octyl)-tetracene-5,6:11,12-tetracarboxylic diimide.

图 16. 本发明实施例4的5,8,13,16–四(乙基)-1,2,3,4,9,10,11,12-八氢环己烷-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺的电化学图。 Figure 16. 5,8,13,16-tetra(ethyl)-1,2,3,4,9,10,11,12-octahydrocyclohexane-N,N'- of Example 4 of the present invention Electrochemical diagram of bis(n-octyl)-tetracene-5,6:11,12-tetracarboxylic acid diimide.

图17. 本发明实施例5的5,8,13,16–四(乙基)-1,2,3,4,9,10,11,12-八氢环己烷-N,N’-二(2,2,3,3,4,4,4–七氟正丁基)-并四苯-5,6:11,12-四羧酸二酰亚胺的质谱图。 Figure 17. 5,8,13,16-tetra(ethyl)-1,2,3,4,9,10,11,12-octahydrocyclohexane-N,N'- of Example 5 of the present invention Mass spectrum of bis(2,2,3,3,4,4,4-heptafluoro-n-butyl)-tetracene-5,6:11,12-tetracarboxylic acid imide.

图18. 本发明实施例5的5,8,13,16–四(乙基)-1,2,3,4,9,10,11,12-八氢环己烷-N,N’-二(2,2,3,3,4,4,4–七氟正丁基)-并四苯-5,6:11,12-四羧酸二酰亚胺的1H-NMR图。 Figure 18. 5,8,13,16-tetra(ethyl)-1,2,3,4,9,10,11,12-octahydrocyclohexane-N,N'- of Example 5 of the present invention 1 H-NMR chart of bis(2,2,3,3,4,4,4-heptafluoro-n-butyl)-tetracene-5,6:11,12-tetracarboxylic acid imide.

图19. 本发明实施例5的5,8,13,16–四(乙基)-1,2,3,4,9,10,11,12-八氢环己烷-N,N’-二(2,2,3,3,4,4,4–七氟正丁基)-并四苯-5,6:11,12-四羧酸二酰亚胺的吸收图。 Figure 19. 5,8,13,16-tetra(ethyl)-1,2,3,4,9,10,11,12-octahydrocyclohexane-N,N'- of Example 5 of the present invention Absorption pattern of bis(2,2,3,3,4,4,4-heptafluoro-n-butyl)-tetracene-5,6:11,12-tetracarboxylic acid imide.

图 20. 本发明实施例5的5,8,13,16–四(乙基)-1,2,3,4,9,10,11,12-八氢环己烷-N,N’-二(2,2,3,3,4,4,4–七氟正丁基)-并四苯-5,6:11,12-四羧酸二酰亚胺的电化学图。 Figure 20. 5,8,13,16-tetra(ethyl)-1,2,3,4,9,10,11,12-octahydrocyclohexane-N,N'- of Example 5 of the present invention Electrochemical diagram of bis(2,2,3,3,4,4,4-heptafluoro-n-butyl)-tetracene-5,6:11,12-tetracarboxylic acid diimide.

具体实施方式 Detailed ways

实施例1;本发明实施例1的1,2,3,4,7,8,9,10–八(乙基)-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺。 Example 1; 1,2,3,4,7,8,9,10-octa(ethyl)-N,N'-bis(n-octyl)-tetracene-5 of Example 1 of the present invention, 6: 11,12-tetracarboxylic diimide.

Figure 511014DEST_PATH_IMAGE013
Figure 511014DEST_PATH_IMAGE013

具体合成步骤是: Concrete synthetic steps are:

1.向1mmol 二氯二茂锆中加入20ml新蒸四氢呋喃,在氮气气体保护下,将溶液放置于-78℃; 1. Add 20ml of freshly distilled tetrahydrofuran to 1mmol of zirconocene dichloride, and place the solution at -78°C under the protection of nitrogen gas;

2.向步骤1的混合物中逐滴滴入2 mmol的正丁基锂,反应60分钟; 2. Add 2 mmol of n-butyllithium dropwise to the mixture in step 1, and react for 60 minutes;

3.60分钟后,向步骤2制备的混合物中加入2 mmol的3-己炔,移置室温反应2个小时; 3. After 60 minutes, add 2 mmol of 3-hexyne to the mixture prepared in step 2, and react at room temperature for 2 hours;

4.反应结束后,在真空低温状态下将四氢呋喃抽走10 ml,依次加入300 mg的2,3:6,7-四溴-N, N’-二(正辛基)-萘-5,6:11,12-四羧酸二酰亚胺,200 mg氯化亚铜, 氮气保护下,50℃下反应4 h.产物经二氯甲烷萃取,无水硫酸钠干燥,过滤,50℃以下蒸干溶剂,硅胶柱层析分离得到产物1,2,3,4,7,8,9,10–八(乙基)-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺165 mg,产率为 55%。暗红色粉末,MS(MALDI-TOF,m/z): 814.6. Anal.Calcd for: C54H74O2N(分子量:814.6 ); 1H-NMR(CDCl3,400MHZ):δ = 4.27 (m, 4H), 3.02-3.07 (m, 8H), 2.86-2.87 (m, 8H), 1.82-1.86 (m, 4H), 1.47-1.49 (m, 4H), 1.28-1.36 (m, 28H),0.79-0.87 (m, 18H). 4. After the reaction is over, remove 10 ml of tetrahydrofuran under vacuum and low temperature, and then add 300 mg of 2,3:6,7-tetrabromo-N, N'-di(n-octyl)-naphthalene-5, 6: 11,12-tetracarboxylic diimide, 200 mg cuprous chloride, under nitrogen protection, react at 50°C for 4 h. The product is extracted with dichloromethane, dried over anhydrous sodium sulfate, filtered, below 50°C The solvent was evaporated to dryness, and the products 1,2,3,4,7,8,9,10-octa(ethyl)-N,N'-bis(n-octyl)-tetracene-5 were obtained by silica gel column chromatography ,6:11,12-tetracarboxylic diimide 165 mg, the yield was 55%. Dark red powder, MS(MALDI-TOF,m/z): 814.6. Anal.Calcd for: C 54 H 74 O 2 N 4 (molecular weight: 814.6 ); 1 H-NMR(CDCl 3 ,400MHZ): δ = 4.27 (m, 4H), 3.02-3.07 (m, 8H), 2.86-2.87 (m, 8H), 1.82-1.86 (m, 4H), 1.47-1.49 (m, 4H), 1.28-1.36 (m, 28H) ,0.79-0.87 (m, 18H).

1,2,3,4,7,8,9,10–八(乙基)-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺的质谱如图1所示;1H-NMR图如图2所示;紫外可见吸收图如图3所示;电化学图如图4所示。 1,2,3,4,7,8,9,10-octa(ethyl)-N,N'-di(n-octyl)-tetracene-5,6:11,12-tetracarboxylic acid di Figure 1 shows the mass spectrum of the imide; Figure 2 shows the 1 H-NMR chart; Figure 3 shows the ultraviolet-visible absorption chart; Figure 4 shows the electrochemical chart.

实施例2;1,2,3,4,7,8,9,10–八(乙基)-N,N’-二(2,2,3,3,4,4,4–七氟正丁基)-并四苯-5,6:11,12-四羧酸二酰亚胺。 Example 2; 1,2,3,4,7,8,9,10-octa(ethyl)-N,N'-di(2,2,3,3,4,4,4-heptafluoro-n- Butyl)-tetracene-5,6:11,12-tetracarboxylic acid diimide.

Figure 11266DEST_PATH_IMAGE014
Figure 11266DEST_PATH_IMAGE014

具体合成步骤是: Concrete synthetic steps are:

1.向1mmol 二氯二茂锆中加入20ml 新蒸四氢呋喃,在氮气气体保护下,将溶液放置于-78℃; 1. Add 20ml of freshly distilled tetrahydrofuran to 1mmol of zirconocene dichloride, and place the solution at -78°C under the protection of nitrogen gas;

2.向步骤1的混合物中逐滴滴入2 mmol的正丁基锂,反应60分钟; 2. Add 2 mmol of n-butyllithium dropwise to the mixture in step 1, and react for 60 minutes;

3.60分钟后,向步骤2制备的混合物中加入2 mmol的3-己炔,移置室温反应2个小时; 3. After 60 minutes, add 2 mmol of 3-hexyne to the mixture prepared in step 2, and react at room temperature for 2 hours;

4.反应结束后,在真空低温状态下将四氢呋喃抽走10 ml,依次加入300 mg的2,3:6,7-四溴-N,N’-二(2,2,3,3,4,4,4–七氟正丁基)-萘-5,6:11,12-四羧酸二酰亚胺,200 mg氯化亚铜, 氮气保护下,50下反应4 h.产物经二氯甲烷萃取,无水硫酸钠干燥,过滤,60℃以下蒸干溶剂,硅胶柱层析分离得到产物1,2,3,4,7,8,9,10–八(乙基)-N,N’-二(2,2,3,3,4,4,4–七氟正丁基)-并四苯-5,6:11,12-四羧酸二酰亚胺 132mg, 产率为44%。暗红色粉末,MS(MALDI-TOF,m/z): 954.5. Anal.Calcd for: C46H44F14N2O(分子量:954.3); 1H-NMR (CDCl3, 400 MHZ):δ = 5.07 (m, 4H), 2.87-3.01 (m, 16H), 1.26-1.34 (m, 12H), 0.81-0.84 (m, 12H)。 4. After the reaction, 10 ml of tetrahydrofuran was sucked away under vacuum and low temperature, and 300 mg of 2,3:6,7-tetrabromo-N,N'-bis(2,2,3,3,4 ,4,4-heptafluoro-n-butyl)-naphthalene-5,6:11,12-tetracarboxylic acid diimide, 200 mg cuprous chloride, under nitrogen protection, react at 50 for 4 h. Extracted with methyl chloride, dried over anhydrous sodium sulfate, filtered, evaporated to dryness below 60°C, and separated by silica gel column chromatography to obtain products 1,2,3,4,7,8,9,10-octa(ethyl)-N, N'-bis(2,2,3,3,4,4,4-heptafluoro-n-butyl)-tetracene-5,6:11,12-tetracarboxylic acid diimide 132mg, the yield is 44%. Dark red powder, MS(MALDI-TOF,m/z): 954.5. Anal.Calcd for: C 46 H 44 F 14 N 2 O 4 (molecular weight: 954.3); 1 H-NMR (CDCl 3 , 400 MHZ): δ = 5.07 (m, 4H), 2.87-3.01 (m, 16H), 1.26-1.34 (m, 12H), 0.81-0.84 (m, 12H).

1,2,3,4,7,8,9,10–八(乙基)-N,N’-二(2,2,3,3,4,4,4–七氟正丁基)-并四苯-5,6:11,12-四羧酸二酰亚胺的质谱图如图5所示;1H-NMR图如图6所示;紫外可见吸收图如图7所示;电化学图如图8所示。 1,2,3,4,7,8,9,10-octa(ethyl)-N,N'-bis(2,2,3,3,4,4,4-heptafluoro-n-butyl)- The mass spectrogram of naphthacene-5,6:11,12-tetracarboxylic diimide is shown in Figure 5; the 1 H-NMR chart is shown in Figure 6; the UV-visible absorption chart is shown in Figure 7; The chemical map is shown in Figure 8.

实施例3;(1,2,3,4,7,8,9,10–八(正丁基)-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺) Example 3; (1,2,3,4,7,8,9,10-octa(n-butyl)-N,N'-bis(n-octyl)-tetracene-5,6:11, 12-tetracarboxylic diimide)

Figure 431883DEST_PATH_IMAGE015
Figure 431883DEST_PATH_IMAGE015

具体合成步骤是: Concrete synthetic steps are:

1.向1mmol 二氯二茂锆中加入20ml 新蒸四氢呋喃,在氮气气体保护下,将溶液放置于-78℃; 1. Add 20ml of freshly distilled tetrahydrofuran to 1mmol of zirconocene dichloride, and place the solution at -78°C under the protection of nitrogen gas;

2.向步骤1的混合物中逐滴滴入2 mmol的正丁基锂,反应60分钟; 2. Add 2 mmol of n-butyllithium dropwise to the mixture in step 1, and react for 60 minutes;

3.60分钟后,向步骤2制备的混合物中加入2 mmol的5-癸炔,移置室温反应2个小时; 3. After 60 minutes, add 2 mmol of 5-decyne to the mixture prepared in step 2, and react at room temperature for 2 hours;

4.反应结束后,在真空低温状态下将四氢呋喃抽走10 ml,依次加入300 mg的2,3:6,7-四溴-N,N’-二(正辛基)-萘-5,6:11,12-四羧酸二酰亚胺,200 mg氯化亚铜, 氮气保护下,55℃下反应4 h.产物经二氯甲烷萃取,无水硫酸钠干燥,过滤,60℃以下蒸干溶剂,硅胶柱层析分离得到产物1,2,3,4,7,8,9,10–八(正丁基)-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺 210mg, 产率为 52%。暗红色粉末,MS(MALDI-TOF,m/z):1038.9. Anal.Calcd for: C70H106N2O4 (分子量, 1038.8 ); 1H-NMR (CDCl3,400MHZ):δ = 4.24 (m, 4H), 2.98-3.02 (m, 8H), 2.72-2.75 (m, 8H), 1.75-1.84 (m, 12H), 1.50-1.60 (m, 12H), 1.29-1.38 (m, 128H), 1.04-1.07(m, 28H), 0.86-0.90 (m, 6H), 0.67-0.70 (m, 12H)。 4. After the reaction is over, remove 10 ml of tetrahydrofuran under vacuum and low temperature, and then add 300 mg of 2,3:6,7-tetrabromo-N,N'-bis(n-octyl)-naphthalene-5, 6: 11,12-tetracarboxylic diimide, 200 mg cuprous chloride, under nitrogen protection, react at 55°C for 4 h. The product is extracted with dichloromethane, dried over anhydrous sodium sulfate, filtered, below 60°C The solvent was evaporated to dryness, and the products 1,2,3,4,7,8,9,10-octa(n-butyl)-N,N'-di(n-octyl)-tetracene- 5,6:11,12-Tetracarboxylic diimide 210mg, yield 52%. Dark red powder, MS(MALDI-TOF,m/z):1038.9. Anal.Calcd for: C 70 H 106 N 2 O 4 (molecular weight, 1038.8 ); 1 H-NMR (CDCl 3 ,400MHZ): δ = 4.24 (m, 4H), 2.98-3.02 (m, 8H), 2.72-2.75 (m, 8H), 1.75-1.84 (m, 12H), 1.50-1.60 (m, 12H), 1.29-1.38 (m, 128H) , 1.04-1.07(m, 28H), 0.86-0.90 (m, 6H), 0.67-0.70 (m, 12H).

1,2,3,4,7,8,9,10–八(正丁基)-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺的质谱图如图9所示;1H-NMR图如图10所示;紫外可见吸收如图11所示; 电化学图如图12所示。 1,2,3,4,7,8,9,10 – octa(n-butyl)-N,N'-di(n-octyl)-tetracene-5,6:11,12-tetracarboxylic acid The mass spectrogram of the imide is shown in Figure 9; the 1 H-NMR chart is shown in Figure 10; the ultraviolet-visible absorption chart is shown in Figure 11; the electrochemical chart is shown in Figure 12.

实施例4(5,8,13,16–四(乙基)-1,2,3,4,9,10,11,12-八氢环己烷-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺) Example 4 (5,8,13,16-tetra(ethyl)-1,2,3,4,9,10,11,12-octahydrocyclohexane-N,N'-bis(n-octyl )-tetracene-5,6:11,12-tetracarboxylic acid diimide)

Figure 904452DEST_PATH_IMAGE016
Figure 904452DEST_PATH_IMAGE016

具体合成步骤是: Concrete synthetic steps are:

1.向1mmol 二氯二茂锆中加入20ml 新蒸四氢呋喃,在氮气气体保护下,将溶液放置于-78℃; 1. Add 20ml of freshly distilled tetrahydrofuran to 1mmol of zirconocene dichloride, and place the solution at -78°C under the protection of nitrogen gas;

2.向步骤1的混合物中逐滴滴入2 mmol的正丁基锂,反应60分钟; 2. Add 2 mmol of n-butyllithium dropwise to the mixture in step 1, and react for 60 minutes;

3.60分钟后,向步骤2制备的混合物中加入1 mmol的3, 9-十二炔,移置室温反应3个小时; 3. After 60 minutes, add 1 mmol of 3, 9-dodedecyne to the mixture prepared in step 2, and react at room temperature for 3 hours;

4.反应结束后,在真空低温状态下将四氢呋喃抽走10 ml,依次加入300 mg的2,3:6,7-四溴-N,N’-二(正辛基)-萘-5,6:11,12-四羧酸二酰亚胺,200 mg氯化亚铜, 氮气保护下,55℃下反应4 h.产物经二氯甲烷萃取,无水硫酸钠干燥,过滤,60℃以下蒸干溶剂,硅胶柱层析分离得到产物5,8,13,16–四(乙基)-1,2,3,4,9,10,11,12-八氢环己烷-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺 144mg, 产率为48%。暗红色粉末,MS(MALDI-TOF,m/z): 810.6 . Anal.Calcd for: C54H70N2O4 (分子量:810.5); 1H-NMR(CDCl3,400MHZ):δ = 4.27 (m, 4H), 2.98 (m, 16H), 1.94 (m, 8H), 1.83 (m, 4H), 1.27-1.37 (m, 20H), 0.83-0.86(m, 18H). 4. After the reaction is over, remove 10 ml of tetrahydrofuran under vacuum and low temperature, and then add 300 mg of 2,3:6,7-tetrabromo-N,N'-bis(n-octyl)-naphthalene-5, 6: 11,12-tetracarboxylic diimide, 200 mg cuprous chloride, under nitrogen protection, react at 55°C for 4 h. The product is extracted with dichloromethane, dried over anhydrous sodium sulfate, filtered, below 60°C The solvent was evaporated to dryness, and the product 5,8,13,16-tetra(ethyl)-1,2,3,4,9,10,11,12-octahydrocyclohexane-N,N was separated by silica gel column chromatography '-bis(n-octyl)-tetracene-5,6:11,12-tetracarboxylic acid diimide 144 mg, yield 48%. Dark red powder, MS(MALDI-TOF,m/z): 810.6 . Anal.Calcd for: C 54 H 70 N 2 O 4 (molecular weight: 810.5); 1 H-NMR(CDCl 3 ,400MHZ): δ = 4.27 (m, 4H), 2.98 (m, 16H), 1.94 (m, 8H), 1.83 (m, 4H), 1.27-1.37 (m, 20H), 0.83-0.86(m, 18H).

5,8,13,16–四(乙基)-1,2,3,4,9,10,11,12-八氢环己烷-N,N’-二(正辛基)-并四苯-5,6:11,12-四羧酸二酰亚胺的质谱图如图13所示;1H-NMR图如图14所示;紫外可见吸收如图15所示; 电化学图如16所示。 5,8,13,16-tetra(ethyl)-1,2,3,4,9,10,11,12-octahydrocyclohexane-N,N'-di(n-octyl)-naphthalene The mass spectrogram of benzene-5,6:11,12-tetracarboxylic diimide is shown in Figure 13; the 1 H-NMR chart is shown in Figure 14; the UV-visible absorption chart is shown in Figure 15; the electrochemical chart is shown in 16.

实施例5;(5,8,13,16–四(乙基)-1,2,3,4,9,10,11,12-八氢环己烷-N,N’-二(2,2,3,3,4,4,4–七氟正丁基)-并四苯-5,6:11,12-四羧酸二酰亚胺) Example 5; (5,8,13,16-tetra(ethyl)-1,2,3,4,9,10,11,12-octahydrocyclohexane-N,N'-di(2, 2,3,3,4,4,4-heptafluoro-n-butyl)-tetracene-5,6:11,12-tetracarboxylic diimide)

Figure 814639DEST_PATH_IMAGE017
Figure 814639DEST_PATH_IMAGE017

具体合成步骤是: Concrete synthetic steps are:

1.向1mmol 二氯二茂锆中加入20ml 新蒸四氢呋喃,在氮气气体保护下,将溶液放置于-78℃; 1. Add 20ml of freshly distilled tetrahydrofuran to 1mmol of zirconocene dichloride, and place the solution at -78°C under the protection of nitrogen gas;

2.向步骤1的混合物中逐滴滴入2 mmol的正丁基锂,反应60分钟; 2. Add 2 mmol of n-butyllithium dropwise to the mixture in step 1, and react for 60 minutes;

3.60分钟后,向步骤2制备的混合物中加入1 mmol的3, 9-十二炔,移置室温反应3个小时; 3. After 60 minutes, add 1 mmol of 3, 9-dodedecyne to the mixture prepared in step 2, and react at room temperature for 3 hours;

4.反应结束后,在真空低温状态下将四氢呋喃抽走10 ml,依次加入300 mg的2,3:6,7-四溴-N,N’-二(2,2,3,3,4,4,4–七氟正丁基)-萘-5,6:11,12-四羧酸二酰亚胺,200 mg氯化亚铜, 氮气保护下,55℃下反应4 h.产物经二氯甲烷萃取,无水硫酸钠干燥,过滤,60℃以下蒸干溶剂,硅胶柱层析分离得到产物5, 8, 13, 16–四(乙基)-1,2,3,4,9,10,11,12-八氢环己烷-N,N’-二(N,N’-二(2,2,3,3,4,4,4–七氟正丁基)-并四苯-5,6:11,12-四羧酸二酰亚胺 105mg, 产率为35%。暗红色粉末,MS(MALDI-TOF,m/z): 950.4 . Anal.Calcd for: C54H70N2O4 (分子量:950.3); 1H-NMR(CDCl3,400MHZ): δ = 5.08 (m, 4H), 2.95-2.94 (m, 16H), 1.94 (m, 8H), 0.87-0.83 (m, 12H). 4. After the reaction, 10 ml of tetrahydrofuran was sucked away under vacuum and low temperature, and 300 mg of 2,3:6,7-tetrabromo-N,N'-bis(2,2,3,3,4 ,4,4-heptafluoro-n-butyl)-naphthalene-5,6:11,12-tetracarboxylic acid diimide, 200 mg cuprous chloride, under nitrogen protection, reacted at 55°C for 4 h. Extracted with dichloromethane, dried over anhydrous sodium sulfate, filtered, evaporated to dryness below 60°C, and separated by silica gel column chromatography to obtain products 5, 8, 13, 16-tetra(ethyl)-1,2,3,4,9 ,10,11,12-Octahydrocyclohexane-N,N'-bis(N,N'-bis(2,2,3,3,4,4,4-heptafluoro-n-butyl)-naphthalene Benzene-5,6:11,12-tetracarboxylic acid diimide 105mg, yield 35%. Dark red powder, MS(MALDI-TOF,m/z): 950.4 . Anal.Calcd for: C 54 H 70 N 2 O 4 (molecular weight: 950.3); 1 H-NMR (CDCl 3 , 400MHZ): δ = 5.08 (m, 4H), 2.95-2.94 (m, 16H), 1.94 (m, 8H), 0.87-0.83 (m, 12H).

5,8,13,16–四(乙基)-1,2,3,4,9,10,11,12-八氢环己烷-(N,N’-二(2,2,3,3,4,4,4–七氟正丁基)-并四苯-5,6:11,12-四羧酸二酰亚胺的质谱图如图17所示;1H-NMR图如图18所示;紫外可见吸收如图19所示; 电化学图如20所示。 5,8,13,16–tetra(ethyl)-1,2,3,4,9,10,11,12-octahydrocyclohexane-(N,N'-bis(2,2,3, The mass spectrum of 3,4,4,4-heptafluoro-n-butyl)-tetracene-5,6:11,12-tetracarboxylic acid diimide is shown in Figure 17; the 1 H-NMR chart is shown in Figure 17 18; the UV-visible absorption is shown in Figure 19; the electrochemical diagram is shown in 20.

Claims (21)

1.并四苯-5,6:11,12-四羧酸二酰亚胺化合物,其具有如下式I结构: 1. Naphthacene-5,6:11,12-tetracarboxylic acid diimide compound, which has the following formula I structure:
Figure 664248DEST_PATH_IMAGE001
Figure 664248DEST_PATH_IMAGE001
其中: in: R1、R2、R3、R4、R5、R6、R7、R8、R9和R10,相同或不同,分别独立地代表氢、取代或未被取代的,C1-30烷基、C1-30烷氧基、C3-30环烷基、C5-30芳基、C1-30烷基芳基、C1-30烷基杂芳基、C1-30烷基杂环基、C1-30亚烷基氧基烷基、C1-30亚烷基氧基芳基、C1-30亚烷基氧基杂芳基、C1-30亚烷基氧基杂环基, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 , the same or different, independently represent hydrogen, substituted or unsubstituted, C1-30 Alkyl, C1-30 alkoxy, C3-30 cycloalkyl, C5-30 aryl, C1-30 alkylaryl, C1-30 alkyl heteroaryl, C1-30 alkyl heterocyclic, C1 -30 alkyleneoxyalkyl, C1-30 alkyleneoxyaryl, C1-30 alkyleneoxyheteroaryl, C1-30 alkyleneoxyheterocyclic, 其中,任选地,R3和R4一起形成,取代或未被取代的,C3-30环烷基、C5-30芳基、C1-30烷基芳基、C1-30烷基杂芳基、C1-30烷基杂环基、C1-30亚烷基氧基芳基、C1-30亚烷基氧基杂芳基、C1-30亚烷基氧基杂环基, Wherein, optionally, R3 and R4 form together, substituted or unsubstituted, C3-30 cycloalkyl, C5-30 aryl, C1-30 alkylaryl, C1-30 alkylheteroaryl , C1-30 alkylene heterocyclic group, C1-30 alkylene oxyaryl group, C1-30 alkylene oxyheteroaryl group, C1-30 alkylene oxyheterocyclic group, 其中,任选地,R8和R9一起形成,取代或未被取代的,C3-30环烷基、C5-30芳基、C1-30烷基芳基、C1-30烷基杂芳基、C1-30烷基杂环基、C1-30亚烷基氧基芳基、C1-30亚烷基氧基杂芳基、C1-30亚烷基氧基杂环基, Wherein, optionally, R 8 and R 9 form together, substituted or unsubstituted, C3-30 cycloalkyl, C5-30 aryl, C1-30 alkylaryl, C1-30 alkylheteroaryl , C1-30 alkylene heterocyclic group, C1-30 alkylene oxyaryl group, C1-30 alkylene oxyheteroaryl group, C1-30 alkylene oxyheterocyclic group, 条件是:R2、R3、R4、R5、R7、R8、R9和R10不同时为氢。 Provided that R 2 , R 3 , R 4 , R 5 , R 7 , R 8 , R 9 and R 10 are not simultaneously hydrogen.
2.如权利要求1所述化合物,其中R3和R4一起形成,或R8和R9一起形成,下述基团:取代或未被取代的,C3-30环烷基、C5-30芳基、C1-30烷基芳基、C1-30烷基杂芳基、C1-30烷基杂环基、C1-30亚烷基氧基芳基、C1-30亚烷基氧基杂芳基、C1-30亚烷基氧基杂环基。 2. The compound as claimed in claim 1, wherein R 3 and R 4 form together, or R 8 and R 9 form together, the following groups: substituted or unsubstituted, C3-30 cycloalkyl, C5-30 Aryl, C1-30 alkylaryl, C1-30 alkylheteroaryl, C1-30 alkylheterocyclyl, C1-30 alkyleneoxyaryl, C1-30 alkyleneoxyheteroaryl Group, C1-30 alkyleneoxyheterocyclic group. 3.如权利要求1或2所述化合物,其中芳基选自,取代或未被取代的,苯基,萘基,蒽基,菲基,并四苯基,并五苯基,并六苯基,芘基,茚基,联苯基,芴基。 3. The compound as claimed in claim 1 or 2, wherein aryl is selected from, substituted or unsubstituted, phenyl, naphthyl, anthracenyl, phenanthrenyl, naphthacene, pentaphenyl, hexacene Base, pyrenyl, indenyl, biphenyl, fluorenyl. 4.如权利要求1-3任一项所述化合物,其中杂环基选自,取代或未被取代的,噻吩基、呋喃基、吡喃基、吩
Figure 888556DEST_PATH_IMAGE002
噻基、吡咯基、咪唑基、吡唑基、吡啶基、吡嗪基、嘧啶基、哒嗪基、吲嗪基、吲哚基、异吲哚基基、吲唑基、嘌呤基、喹嗪基、喹啉基、酞嗪基、萘啶基、喹喔啉基、蝶啶基、咔唑基、咔啉基、菲啶基、菲咯啉基、吖啶基、吩嗪基、噻唑基、吩噻嗪基、唑基、吩
Figure 60835DEST_PATH_IMAGE002
嗪基、
Figure 473361DEST_PATH_IMAGE002
唑基、二唑基、呋咱基、二噻吩并吡咯基、三并噻吩基、苯并
Figure 479680DEST_PATH_IMAGE002
唑基、苯并咪唑基、苯并噻吩基、苯并噻唑基、苯并噻吩基、苯并呋喃基、苯并吡喃基、苯并吩
Figure 934933DEST_PATH_IMAGE002
噻基、苯并吡咯基、苯并咪唑基、苯并吡唑基、苯并吡啶基、苯并吡嗪基、苯并嘧啶基、苯并哒嗪基、苯并吲嗪基、苯并吲哚基、苯并吲唑基、苯并嘌呤基、苯并喹嗪基、苯并喹啉基、苯并酞嗪基、苯并萘啶基、苯并喹喔啉基、苯并蝶啶基、苯并咔唑基、苯并咔啉基、苯并菲啶基、苯并菲咯啉基、苯并吖啶基、苯并吩嗪基、苯并噻唑基、苯并吩噻嗪基、苯并
Figure 897072DEST_PATH_IMAGE002
唑基、苯并吩
Figure 463183DEST_PATH_IMAGE002
嗪基、或上述基团的环与上述权利要求2所定义芳基的环稠合衍生的基团,或上述基团的组合,这些取代基中的每一个可以另外被取代。
4. The compound according to any one of claims 1-3, wherein the heterocyclic group is selected from, substituted or unsubstituted, thienyl, furyl, pyranyl, phen
Figure 888556DEST_PATH_IMAGE002
Thiyl, pyrrolyl, imidazolyl, pyrazolyl, pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, indolyl, indolyl, isoindolyl, indazolyl, purinyl, quinozine Base, quinolinyl, phthalazinyl, naphthyridinyl, quinoxalinyl, pteridinyl, carbazolyl, carbalinyl, phenanthridinyl, phenanthrolinyl, acridinyl, phenazinyl, thiazolyl , phenothiazinyl, Azolyl, phen
Figure 60835DEST_PATH_IMAGE002
Azinyl,
Figure 473361DEST_PATH_IMAGE002
Azolyl, Diazolyl, furazanyl, dithienopyrrolyl, trithienyl, benzo
Figure 479680DEST_PATH_IMAGE002
Azolyl, benzimidazolyl, benzothienyl, benzothiazolyl, benzothienyl, benzofuryl, benzopyranyl, benzophene
Figure 934933DEST_PATH_IMAGE002
Thiyl, benzopyrrolyl, benzoimidazolyl, benzopyrazolyl, benzopyridyl, benzopyrazinyl, benzopyrimidinyl, benzopyridazinyl, benzoindolizinyl, benzoin Indolyl, benzoindazolyl, benzopurinyl, benzoquinazinyl, benzoquinolinyl, benzophthalazinyl, benzonaphthyridinyl, benzoquinoxalinyl, benzopteridinyl , benzocarbazolyl, benzocarbolinyl, benzophenanthridinyl, benzophenanthrolinyl, benzoacridinyl, benzophenazinyl, benzothiazolyl, benzophenothiazinyl, Benzo
Figure 897072DEST_PATH_IMAGE002
Azolyl, benzophene
Figure 463183DEST_PATH_IMAGE002
An azinyl group, or a group derived from ring fusion of the above-mentioned group and an aryl group as defined in claim 2 above, or a combination of the above-mentioned groups, each of these substituents may be additionally substituted.
5.如权利要求1-4任一项所述化合物,其中烷基选自,取代或未被取代的甲基,乙基,丙基,异丙基,正丁基,仲丁基,异丁基,叔丁基,戊基,己基,庚基,辛基,壬基、癸基、十一碳烷基、十二碳烷基、十三碳烷基、十四碳烷基、十五碳烷基、十六碳烷基、十七碳烷基、十八碳烷基、十九碳烷基和二十碳烷基。 5. The compound according to any one of claims 1-4, wherein the alkyl group is selected from, substituted or unsubstituted methyl, ethyl, propyl, isopropyl, n-butyl, sec-butyl, isobutyl Base, tert-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl Alkyl, hexadecanyl, heptadecanyl, octadecyl, nonadecanyl and eicosyl. 6.如权利要求1-5任一项所述化合物,其中烷氧基选自,取代或未被取代的甲氧基,乙氧基,丙氧基,异丙氧基,正丁氧基,仲丁氧基,异丁氧基,叔丁氧基,戊氧基,己氧基,庚氧基,辛氧基,壬氧基、癸氧基、十一碳烷氧基、十二碳烷氧基、十三碳烷氧基、十四碳烷氧基、十五碳烷氧基、十六碳烷氧基、十七碳烷氧基、十八碳烷氧基、十九碳烷氧基和二十碳烷氧基。 6. The compound according to any one of claims 1-5, wherein the alkoxy group is selected from the group consisting of substituted or unsubstituted methoxy, ethoxy, propoxy, isopropoxy, n-butoxy, sec-butoxy, isobutoxy, tert-butoxy, pentyloxy, hexyloxy, heptyloxy, octyloxy, nonyloxy, decyloxy, undecyloxy, dodecane Oxygen, Tridecyloxy, Tetradecyloxy, Pentadecyloxy, Hexadecanyloxy, Heptadecanyloxy, Octadecanyloxy, Nonadecanyloxy group and eicosyloxy group. 7.如权利要求1-6任一项所述化合物,其中亚烷基选自,取代或未被取代的亚甲基、亚乙基、亚丙基、亚异丙基、亚正丁基、亚仲丁基、亚异丁基、亚叔丁基、亚戊基、亚己基、亚庚基、亚辛基、亚壬基、亚癸基、亚十一碳烷基、亚十二碳烷基、亚十三碳烷基、亚十四碳烷基、亚十五碳烷基、亚十六碳烷基、亚十七碳烷基、亚十八碳烷基、亚十九碳烷基和亚二十碳烷基。 7. The compound according to any one of claims 1-6, wherein the alkylene group is selected from the group consisting of substituted or unsubstituted methylene, ethylene, propylene, isopropylidene, n-butylene, S-butylene, isobutylene, tert-butylene, pentylene, hexylene, heptylene, octylene, nonylene, decylene, undecylene, dodecylene Tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecanyl, octadecylene, nonadecanyl and eicosanylene. 8.如权利要求1-7任一项所述化合物,其中环烷基选自,取代或未被取代的环丁基、环戊基、环己基、环庚基、环辛基、环壬基、环癸基、十一碳环烷基、十二碳环烷基、十三碳环烷基、十四碳环烷基、十五碳环烷基、十六碳环烷基、十七碳环烷基、十八碳环烷基、十九碳环烷基和二十碳环烷基。 8. The compound according to any one of claims 1-7, wherein the cycloalkyl group is selected from the group consisting of substituted or unsubstituted cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl , Cyclodecyl, Undecylcycloalkyl, Dodecylcycloalkyl, Tridecylcycloalkyl, Tetradecylcycloalkyl, Pentadecylcycloalkyl, Hexadecylcycloalkyl, Heptadecan Cycloalkyl, Octadecylcycloalkyl, Nadecacycloalkyl and Eicoscycloalkyl. 9.如权利要求1-8任一项所述化合物,其中杂芳基选自,取代或未被取代的,吡咯基、吡嗪基、吡啶基、吲哚基、异吲哚基、呋喃基、苯并呋喃基, 、异苯并呋喃基、喹啉基、1-异喹啉基、喹喔啉基、咔唑基、菲啶基、吖啶基、邻二氮杂菲基、吩嗪基、吩噻嗪基、吩噻嗪基、吩
Figure 499272DEST_PATH_IMAGE002
嗪基、唑基、呋呫基、噻吩基。
9. The compound according to any one of claims 1-8, wherein heteroaryl is selected from, substituted or unsubstituted, pyrrolyl, pyrazinyl, pyridyl, indolyl, isoindolyl, furyl , benzofuryl, , isobenzofuryl, quinolinyl, 1-isoquinolyl, quinoxalinyl, carbazolyl, phenanthridinyl, acridinyl, o-phenanthrenyl, phenazine base, phenothiazinyl, phenothiazinyl, phen
Figure 499272DEST_PATH_IMAGE002
Azinyl, Azolyl, furanyl, thienyl.
10.如权利要求1-9任一项所述化合物,其中R1、R2、R3、R4、R5、R6、R7、R8、R9和R10,相同或不同,分别独立地代表卤代C1-30烷基,优选地,全卤代C1-30烷基,其中优选地被氟、氯、溴、碘取代。 10. The compound according to any one of claims 1-9, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are the same or different, Each independently represents a halogenated C1-30 alkyl group, preferably a perhalogenated C1-30 alkyl group, which is preferably substituted by fluorine, chlorine, bromine, or iodine. 11.如权利要求1-10任一项所述化合物,其中所述取代基选自: 11. The compound according to any one of claims 1-10, wherein the substituent is selected from: - 烷基,其具有1-16碳原子, - alkyl, which has 1-16 carbon atoms, - 烷氧基,其具有1-16碳原子, - alkoxy, which has 1-16 carbon atoms, - 芳基,其具有5-16碳原子, - aryl, which has 5-16 carbon atoms, - 环烷基,其具有3-16碳原子, - cycloalkyl, which has 3-16 carbon atoms, - 杂环基团,其具有5-16碳原子,基团其中包含的杂原子T基团选自B, Si, Sn, N, O, S 和 Se; - a heterocyclic group having 5-16 carbon atoms, the heteroatom T group contained in the group is selected from B, Si, Sn, N, O, S and Se; - 杂芳基,其具有1-16碳原子, - heteroaryl, which has 1-16 carbon atoms, - 芳烷基,其具有5-16碳原子,其中烷基部分具有1-16碳原子。 - Aralkyl groups having 5-16 carbon atoms, wherein the alkyl moiety has 1-16 carbon atoms. 12.如权利要求11所述化合物,所述取代基选自: 12. The compound as claimed in claim 11, said substituent is selected from: - 烷基,如甲基,乙基,异丙基,叔丁基,正辛基,正癸基,正十二烷基, 正十四烷基, 正十六烷基或正十八烷基; - Alkyl groups such as methyl, ethyl, isopropyl, tert-butyl, n-octyl, n-decyl, n-dodecyl, n-tetradecyl, n-hexadecyl or n-octadecyl ; - 环烷基,如环丙基,环戊基,或环己基; - Cycloalkyl, such as cyclopropyl, cyclopentyl, or cyclohexyl; - 链烯基,如乙烯基,烯丙基,2-丁烯基,或3-戊烯基;  - Alkenyl, such as vinyl, allyl, 2-butenyl, or 3-pentenyl; - 炔基,如炔丙基或3-戊炔基, - alkynyl, such as propargyl or 3-pentynyl, - 芳基,如苯基,对-甲基苯基,萘基或蒽基; - aryl groups such as phenyl, p-methylphenyl, naphthyl or anthracenyl; - 氨基,如氨基,甲基氨基,二甲基氨基,二乙基氨基,二苄基氨基,二苯基氨基,或二甲苯基氨基; - Amino groups, such as amino, methylamino, dimethylamino, diethylamino, dibenzylamino, diphenylamino, or xylylamino; - 烷氧基,如甲氧基,乙氧基,丁氧基或2-乙基己氧基; - alkoxy, such as methoxy, ethoxy, butoxy or 2-ethylhexyloxy; - 芳氧基,如苯基氧基,1-萘氧基,或2-萘氧基; - Aryloxy, such as phenyloxy, 1-naphthyloxy, or 2-naphthyloxy; - 杂芳氧基,如吡啶基氧基,吡唑基氧基,嘧啶基氧基或喹啉基氧基; - heteroaryloxy, such as pyridyloxy, pyrazolyloxy, pyrimidinyloxy or quinolinyloxy; - 酰基,如乙酰基,苯甲酰基,甲酰基或新戊酰基; - Acyl groups such as acetyl, benzoyl, formyl or pivaloyl; - 烷氧基羰基,如甲氧基羰基或乙氧基羰基; - alkoxycarbonyl, such as methoxycarbonyl or ethoxycarbonyl; -芳氧基羰基,如苯基氧基羰基; - aryloxycarbonyl, such as phenyloxycarbonyl; - 酰氧基,如乙酰氧基或苯甲酰氧基;  - acyloxy groups such as acetoxy or benzoyloxy; - 酰胺基,如乙酰氨基或苯甲酰基氨基; - amido groups such as acetamido or benzoylamino; - 烷氧基羰基氨基,如甲氧基羰基氨基; - alkoxycarbonylamino, such as methoxycarbonylamino; - 芳氧基氧基氨基,如苯基氧基羰基氨基; - aryloxyoxyamino, such as phenyloxycarbonylamino; - 磺酰基氨基,如甲烷磺酰基胺基或苯磺酰基氨基; - Sulfonylamino, such as methanesulfonylamino or benzenesulfonylamino; - 氨磺酰基,如氨基磺酰基,甲基氨基磺酰基,二甲基氨基磺酰基,或苯基氨基磺酰基; - sulfamoyl, such as aminosulfonyl, methylsulfamoyl, dimethylsulfamoyl, or phenylsulfamoyl; - 氨基甲酰基,如氨基甲酰基,甲基氨基甲酰基,二乙基氨基甲酰基,或苯基氨基甲酰基; - carbamoyl, such as carbamoyl, methylcarbamoyl, diethylcarbamoyl, or phenylcarbamoyl; - 烷硫基,如甲硫基或乙硫基; - Alkylthio, such as methylthio or ethylthio; - 芳硫基,如苯硫基; - Arylthio, such as phenylthio; - 杂芳基硫基,如吡啶基硫基,2-苯并咪唑基硫基,2-苯并唑基硫基,或2-苯并噻唑基硫基;  - Heteroarylthio, such as pyridylthio, 2-benzimidazolylthio, 2-benzo Azolylthio, or 2-benzothiazolylthio; - 磺酰基,如甲磺酰基或甲苯磺酰基; - Sulfonyl, such as methylsulfonyl or toluenesulfonyl; - 亚磺酰基,如甲基亚磺酰基或苯亚磺酰基; - sulfinyl groups such as methylsulfinyl or phenylsulfinyl; - 脲基,如脲基,甲基脲基或苯基脲基; - ureido, such as ureido, methylureido or phenylureido; - 磷酸酰胺基,如二乙基磷酸酰胺或苯基磷酰胺; - Phosphate amides, such as diethylphosphoramide or phenylphosphoramide; - 羟基; - Hydroxyl; - 巯基;  - mercapto; - 卤素原子(如氟原子,氯原子,溴原子,或碘原子); - Halogen atom (such as fluorine atom, chlorine atom, bromine atom, or iodine atom); - 氰基; - cyano; - 磺基; - sulfo group; - 羧基; - Carboxyl; - 硝基; - Nitro; - 异羟肟酸基团; - Hydroxamic acid group; - 亚磺基; - sulfinyl group; - 肼基; - hydrazino; - 亚氨基; - imino; -杂环基团,如咪唑基,吡啶基,喹啉基,呋喃基,噻吩基,哌啶基,吗啉代,苯并
Figure 679084DEST_PATH_IMAGE002
唑基,苯并咪唑基,和苯并噻唑基;
- Heterocyclic groups such as imidazolyl, pyridyl, quinolinyl, furyl, thienyl, piperidyl, morpholino, benzo
Figure 679084DEST_PATH_IMAGE002
Azolyl, benzimidazolyl, and benzothiazolyl;
- 甲硅烷基,如三甲基甲硅烷基或三苯基甲硅烷基。 - Silyl groups such as trimethylsilyl or triphenylsilyl.
13.如权利要求1-12任一项所述化合物,它们是: 13. The compound according to any one of claims 1-12, which are:
Figure 399040DEST_PATH_IMAGE003
Figure 196095DEST_PATH_IMAGE004
Figure 804931DEST_PATH_IMAGE005
Figure 399040DEST_PATH_IMAGE003
,
Figure 196095DEST_PATH_IMAGE004
,
Figure 804931DEST_PATH_IMAGE005
Figure 40740DEST_PATH_IMAGE006
Figure 51421DEST_PATH_IMAGE007
Figure 40740DEST_PATH_IMAGE006
or
Figure 51421DEST_PATH_IMAGE007
,
其中Et代表乙基,Bu代表丁基。 Wherein Et represents ethyl, and Bu represents butyl.
14.制备权利要求1-13任一项所述化合物的方法,其包括下述步骤: 14. The method for preparing the compound described in any one of claims 1-13, which comprises the steps of: 1). 使卤代茂金属试剂Cp2LX2与炔化合物B反应,得到式II和/或式III化合物: 1). Reaction of the halogenated metallocene reagent Cp 2 LX 2 with the alkyne compound B to obtain the compound of formula II and/or formula III:
Figure 19377DEST_PATH_IMAGE008
Figure 19377DEST_PATH_IMAGE008
和/或 and / or
Figure 177826DEST_PATH_IMAGE009
Figure 177826DEST_PATH_IMAGE009
其中, in, R1、R2、R3、R4、R5、R6、R7、R8、R9和R10,相同或不同, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are the same or different, 定义如权利要求1-13任一项所定义, Definitions as defined in any one of claims 1-13, Cp代表环戊二烯基或称为茂基, Cp represents cyclopentadienyl or known as cyclopentadienyl, L代表元素周期表中IVA或IVB族金属,如锆或钛, L represents the IVA or IVB group metals in the periodic table of elements, such as zirconium or titanium, X代表卤素,如氟、氯、溴、碘, X represents halogen, such as fluorine, chlorine, bromine, iodine, B代表炔化合物,如R≡R’,R-C≡C-(CH2)n-C≡C-R’’,或R-C≡C-(CH2)n-C≡C-(CH2)n-C≡C-R’’’,其中,R,R’,R’’和R’’’,相同或不同,代表如权利要求1-13任一项所定义的基团或合适的保护基团,如三烃基硅基例如三甲基硅基、三异丙基硅或三苯基甲硅烷基,或芳基如苯基;n=3,4,5,6,7,8,9或10; B represents an alkyne compound, such as R≡R', RC≡C-(CH 2 ) n -C≡C-R'', or RC≡C-(CH 2 ) n -C≡C-(CH 2 ) n - C≡C-R''', wherein R, R', R'' and R''', the same or different, represent a group as defined in any one of claims 1-13 or a suitable protecting group , such as trihydrocarbylsilyl such as trimethylsilyl, triisopropylsilyl or triphenylsilyl, or aryl such as phenyl; n=3,4,5,6,7,8,9 or 10 ; 2). 使式IV四卤代四羧酸萘二酰亚胺化合物与前述步骤得到的式II和或式III化合物反应,得到式I化合物: 2). The compound of formula IV tetrahalogenated tetracarboxylic naphthalene diimide reacts with the compound of formula II and or formula III obtained in the previous step to obtain the compound of formula I:
Figure 623851DEST_PATH_IMAGE011
Figure 623851DEST_PATH_IMAGE011
其中, in, R1、R2、R3、R4、R5、R6、R7、R8、R9和R10,相同或不同, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are the same or different, 定义如权利要求1-13任一项所定义, Definitions as defined in any one of claims 1-13, X,相同或不同,代表卤素,如氟、氯、溴、碘。 X, same or different, represents halogen, such as fluorine, chlorine, bromine, iodine.
15.如权利要求14所述方法,其中,步骤1)中,将式VI化合物中加入溶剂,式VI化合物与溶剂的比例为0.01~1.0mmol/ml。 15. The method according to claim 14, wherein, in step 1), a solvent is added to the compound of formula VI, and the ratio of the compound of formula VI to the solvent is 0.01-1.0 mmol/ml. 16.如权利要求14或15所述方法,其中,四卤代四羧酸萘二酰亚胺化合物与式VI化合物的摩尔比例为1:1~10。 16. The method according to claim 14 or 15, wherein the molar ratio of the tetrahalogenated tetracarboxylic naphthalene diimide compound to the compound of formula VI is 1:1-10. 17.如权利要求14-16任一项所述方法,其中,向步骤1)产物中加入催化剂,催化剂与四卤代四羧酸萘二酰亚胺化合物摩尔比为10:1~1。 17. The method according to any one of claims 14-16, wherein a catalyst is added to the product of step 1), and the molar ratio of the catalyst to the tetrahalogenated tetracarboxylic naphthalene diimide compound is 10:1-1. 18.如权利要求14-17任一项所述方法,其中,反应温度控制在0℃~70℃。 18. The method according to any one of claims 14-17, wherein the reaction temperature is controlled at 0°C to 70°C. 19.如权利要求17或18所述方法,其中,所述的催化剂为氯化亚铜。 19. The method according to claim 17 or 18, wherein the catalyst is cuprous chloride. 20.权利要求1-13任一项所述化合物在有机电致发光器件、有机热致色变元件、有机场效应晶体管、有机太阳能电池中作为吸光材料和电子传输材料的应用。 20. The application of the compound according to any one of claims 1-13 as a light-absorbing material and an electron-transporting material in organic electroluminescent devices, organic thermochromic elements, organic field-effect transistors, and organic solar cells. 21.有机电致发光器件、有机热致色变元件、有机场效应晶体管或有机太阳能电池,其包含权利要求1-13任一项所述化合物。 21. An organic electroluminescent device, an organic thermochromic element, an organic field effect transistor or an organic solar cell, comprising the compound according to any one of claims 1-13.
CN2011100334121A 2011-01-31 2011-01-31 Tetracene-5,6:11,12-tetrabasic carboxylic acid diimide compound and preparation method thereof Pending CN102617572A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN2011100334121A CN102617572A (en) 2011-01-31 2011-01-31 Tetracene-5,6:11,12-tetrabasic carboxylic acid diimide compound and preparation method thereof
PCT/CN2012/000096 WO2012103776A1 (en) 2011-01-31 2012-01-19 Naphthacene-5,6:11,12-tetracarboxylic acid diimide compound and preparation method therefor
TW101102697A TW201309697A (en) 2011-01-31 2012-01-20 Naphthacene-5,6:11,12-tetracarboxylic acid diimide compound and preparation method therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011100334121A CN102617572A (en) 2011-01-31 2011-01-31 Tetracene-5,6:11,12-tetrabasic carboxylic acid diimide compound and preparation method thereof

Publications (1)

Publication Number Publication Date
CN102617572A true CN102617572A (en) 2012-08-01

Family

ID=46557828

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011100334121A Pending CN102617572A (en) 2011-01-31 2011-01-31 Tetracene-5,6:11,12-tetrabasic carboxylic acid diimide compound and preparation method thereof

Country Status (3)

Country Link
CN (1) CN102617572A (en)
TW (1) TW201309697A (en)
WO (1) WO2012103776A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106062086A (en) * 2014-01-16 2016-10-26 洛桑联邦理工学院 Hole transporting and light absorbing material for solid state solar cells
CN106558654A (en) * 2015-09-30 2017-04-05 北京鼎材科技有限公司 A kind of phenonaphthazine derivant and its application in organic electroluminescence device
CN109776533A (en) * 2019-02-12 2019-05-21 宁波卢米蓝新材料有限公司 A kind of benzene-naphthalene diimide derivative and its preparation method and application
CN110759919A (en) * 2018-12-06 2020-02-07 广州华睿光电材料有限公司 Pyrene quinone organic compound and application thereof
CN111196819A (en) * 2018-11-16 2020-05-26 中国科学院上海药物研究所 A kind of D-A-D type benzopyrazine compound and preparation method and application
CN112300200A (en) * 2020-11-21 2021-02-02 东华理工大学 A-D-A type structure organic small molecule photovoltaic material

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7259260B2 (en) * 2001-10-22 2007-08-21 Mitsui Chemicals, Inc. Imide compound and optical recording media made by using the same
JP2003165273A (en) * 2001-11-30 2003-06-10 Mitsui Chemicals Inc Optical recording medium and optical recorder
JP2004090372A (en) * 2002-08-30 2004-03-25 Mitsui Chemicals Inc Optical recording medium
CN100567294C (en) * 2005-12-30 2009-12-09 财团法人工业技术研究院 N-type organic semiconductor material

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106062086A (en) * 2014-01-16 2016-10-26 洛桑联邦理工学院 Hole transporting and light absorbing material for solid state solar cells
CN106558654A (en) * 2015-09-30 2017-04-05 北京鼎材科技有限公司 A kind of phenonaphthazine derivant and its application in organic electroluminescence device
CN106558654B (en) * 2015-09-30 2020-01-14 北京鼎材科技有限公司 Benzophenazine derivative and application thereof in organic electroluminescent device
CN111196819A (en) * 2018-11-16 2020-05-26 中国科学院上海药物研究所 A kind of D-A-D type benzopyrazine compound and preparation method and application
CN111196819B (en) * 2018-11-16 2023-03-28 中国科学院上海药物研究所 D-A-D type benzopyrazines compound, preparation method and application thereof
CN110759919A (en) * 2018-12-06 2020-02-07 广州华睿光电材料有限公司 Pyrene quinone organic compound and application thereof
CN109776533A (en) * 2019-02-12 2019-05-21 宁波卢米蓝新材料有限公司 A kind of benzene-naphthalene diimide derivative and its preparation method and application
CN109776533B (en) * 2019-02-12 2020-10-30 宁波卢米蓝新材料有限公司 Naphthalene diimide derivative and preparation method and application thereof
CN112300200A (en) * 2020-11-21 2021-02-02 东华理工大学 A-D-A type structure organic small molecule photovoltaic material

Also Published As

Publication number Publication date
WO2012103776A1 (en) 2012-08-09
TW201309697A (en) 2013-03-01

Similar Documents

Publication Publication Date Title
CN104045623B (en) Compound, method for producing the same, and organic electronic device using the same
CN101090893B (en) New imidazole derivatives, preparation method thereof and organic electronic device using the same
KR100642995B1 (en) New compound and organic light emitting device using the same8
KR101317501B1 (en) Novel compound, derivatives thereof and organic electronic device using the same
CN107709330B (en) Spiro compound and organic light-emitting element comprising same
CN102617572A (en) Tetracene-5,6:11,12-tetrabasic carboxylic acid diimide compound and preparation method thereof
CN101153036A (en) Organic light-emitting compound and organic light-emitting device containing it
KR20090089332A (en) Novel carbazole derivatives and their use
WO2007064104A1 (en) Quinacridine derivatives and organic electronic devices using the same
CN112409276B (en) A compound and its application
CN111225905B (en) Heterocyclic compound and organic light-emitting device comprising same
CN108546267A (en) A kind of organic conjugate small molecule material of end group chain containing naphthenic base and preparation method thereof and application in solar cells
WO2023284103A1 (en) Organic compound and application thereof
CN108699074A (en) The compound of spirane structure and organic electronic device comprising it
KR100925323B1 (en) Novel compound and organic light emitting device using same
CN102010415B (en) Heterocyclic compound and organic luminescence display device including the same
CN102112470B (en) Perylene tetracarboximide derivatives for photovoltaic devices
CN102659790A (en) Organic luminescent material and preparation method and application thereof
JP2022020601A (en) Novel organic electroluminescent material, and element of the same
CN111356696B (en) Heterocyclic compound and organic light-emitting device comprising same
CN117024459A (en) Organic compound and application thereof
CN103265555B (en) Si Suo Suan perylene diimides compound and preparation method thereof and application
CN108570067B (en) Silole fused perylene imide derivative and preparation method thereof
CN111848619A (en) Organic photoelectric material and preparation method and application thereof
TWI471308B (en) Organic compound and organic electroluminescent device therewith

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120801